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CHAPTER 1
INTRODUCTION
Cardiolipin (CL) is the signature phospholipid of mitochondria. It is synthesized and
predominantly localized in the inner mitochondrial membrane (IMM) (Hostetler et al. 1972;
Joshi et al. 2009). Unlike a typical phospholipid with one phosphate group and two acyl
chains, CL contains four acyl chains and two phosphate groups that are connected by a
glycerol backbone (Lecocq and Ballou 1964; Pangborn 1947). This composition gives
rise to a conical shape, resulting in an intrinsic curvature that predisposes CL to localize
in highly concave regions of the IMM, facilitating the formation of cristae and supporting
the high membrane dynamics (Beltran-Heredia et al. 2019; Lewis and McElhaney 2009)
(Fig. 1-1). The negative charges of the two phosphate groups at physiologic pH and
hydrophobicity of the acyl chains enable CL to interact with proteins and protein
complexes by non-covalent bonds and function as a chaperone (Claypool 2009; Schlame
et al. 2000; Schlame and Ren 2009). This interaction also shifts the associationdissociation equilibrium of mitochondrial supercomplexes towards association, which is
essential for organizing complex arrays such as the ATP synthase dimer ribbon (Ren et
al. 2014; Schlame and Greenberg 2017).
The importance of studying CL is underscored by the severity of the X-linked
human disorder Barth syndrome (BTHS), which is caused by mutations in the CL
remodeling gene tafazzin (TAZ) (Barth et al. 1983). Although the mechanism whereby CL
and its remodeling cause the pathological phenotypes of BTHS has been intensively
studied in the past two decades, the unknowns remain vast.
1. Synthesis and remodeling of cardiolipin (CL)
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PL bilayer

Figure 1-1. Cardiolipin (CL) is a unique phospholipid (PL).
Biological bilayers are composed of phospholipids and are essential in cellular
compartmentalization. Unlike other PLs, including phosphatidylcholine (PC),
phosphatidylethanolamine (PE), phosphatidylglycerol (PG), phosphatidylinositol (PI),
and phosphatidylserine (PS), which contain one phosphate head group and two acyl
chains, CL has two phosphate head groups that are connected by a glycerol backbone
and four acyl chains. The composition of CL leads to its conical shape and intrinsic
curvature, which enable localization of CL in the concave area of a membrane, facilitating
the formation of cristae in mitochondria.
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The CL synthesis and remodeling pathway is highly conserved from yeast to
humans. Phosphatidic acid (PA) is converted to CL in mitochondria. It has been shown
that PA is synthesized in two proximate sites in cells: the endoplasmic reticulum (ER)
and the outer surface of the outer mitochondrial membrane (OMM) (Chakraborty et al.
1999; B. J. Ma et al. 1999). Although it remains unclear which site primarily provides PA
for CL synthesis, in either case, translocation of PA from the OMM to the matrix face of
the IMM is required. The lipid transport activity of Ups1p is facilitated by the binding of a
mitochondrial intermembrane space (IMS) protein Mdm35p (Potting et al. 2010; Y.
Tamura et al. 2010). The synthesis of CL from PA is a four-step process that is highly
conserved from yeast to humans (Fig.1-1). All enzymes in this pathway have been
identified in yeast. Tam41 catalyzes the transformation of PA to the high-energy
phosphoanhydride intermediate cytidine diphosphate diacylglycerol (phosphatidyl-CMP
or CDP-DAG) (Kutik et al. 2008). Cds1, which is exclusively localized in the ER, also
catalyzes the formation of CDP-DAG (Y. He et al. 2014b; Yasushi Tamura et al. 2013).
Overexpression of Cds1 in tam41Δ cells does not restore the mitochondrial CL level,
suggesting that there are independent pools of CDP-DAG in the ER and mitochondria
(Yasushi Tamura et al. 2013). Pgs1 is phosphatidylglycerolphosphate (PGP) synthase,
which catalyzes the formation of PGP by transferring a phosphatidyl group from CDPDAG to sn-glycerol-3-phosphate (G3P) (Chang et al. 1998a). Gep4 dephosphorylates
PGP to form phosphatidylglycerol (PG) (Osman et al. 2010). In mammalian cells, the
dephosphorylation of PGP is catalyzed by the tyrosine phosphatase PTPMT1. Although
structurally different from Gep4, PTPMT1 functionally replaces yeast Gep4 in the gep4
mutant (J. Zhang et al. 2011). In the last step of CL synthesis, Crd1 (previously named
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Figure 1-2. CL synthesis and remodeling in human and yeast cells.
The CL synthesis and remodeling pathways are conserved in eukaryotic cells.
Phosphatidic acid (PA) is imported to the inner mitochondrial membrane (IMM) by Ups1Mdm35 complex. At IMM, PA is converted to cytidine diphosphate diacylglycerol (CDPDAG) (Chakraborty et al. 1999). Phosphatidylglycerolphosphate (PGP) synthase 1
(PGS1 in human and Pgs1 in yeast) converts CDP-DAG to PGP, which is
dephosphorylated to phosphatidylglycerol (PG) by the PGP phosphatase activity of
PTPMT1 in humans or Gep4 in yeast (Chang et al. 1998a; Hostetler et al. 1971, 1972;
Osman et al. 2010). CL synthase (hCLS in humans and Crd1 in yeast) synthesizes CL
from CDP-DAG and PG (Jiang et al. 1997, Jiang et al. 2000, Chen et al. 2006,
Houtkooper et al. 2006). The acyl chains on the de novo synthesized CL are primarily
saturated. A phospholipase A2 (iPLA2) (Cld1 in yeast) deacylates CL to form
monolysocardiolipin (MLCL), which is reacylated by tafazzin (Beranek et al. 2009;
Malhotra et al. 2009; Mancuso et al. 2009; Vreken et al. 2000; Xu et al. 2006a). The
cycle of deacylation and reacylation is called remodeling and results in unsaturated CL
species.
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Cls1) synthesizes CL by transferring a phosphatidyl group from CDP-DAG to PG (Chang
et al. 1998b; Schlame and Greenberg 1997). CL synthase was first shown to reside in the
IMM in rat liver (Schlame and Haldar 1993). Human CL synthase, identified as hCLS1 or
HsCLS, is highly homologous to yeast Crd1 (Chang et al. 1998b; D. Chen et al. 2006;
Houtkooper et al. 2006; Jiang et al. 1997; Jiang et al. 2000).
CL that is synthesized de novo undergoes a remodeling process in which saturated
acyl chains are exchanged with unsaturated species by repeated cycles of deacylation
and reacylation. A calcium-independent phospholipase A2 (iPLA2) (Cld1 in yeast) and a
CoA-independent, acyl-specific transacylase (tafazzin, TAZ) catalyze the deacylation and
reacylation, respectively (Beranek et al. 2009; Malhotra et al. 2009; Mancuso et al. 2009;
Vreken et al. 2000; Xu et al. 2006a). The phospholipid-lysophospholipid transacylase
activity of TAZ transfers acyl chains between monolysocardiolipin (MLCL) and PE or PC,
or between CL and lyso-PE or PC (LPE, LPC), which means TAZ can carry out
remodeling by direct transacylation in a phospholipase-independent manner (Xu et al.
2003; Xu et al. 2006a). The increased ratio of MLCL to total CL, rather than decreased
synthesis of unsaturated CL, causes mitochondrial dysfunction in the yeast BTHS model
taz1Δ (Baile et al. 2014; Ye et al. 2014). However, with a more complicated and more
oxidizable CL profile in mammalian cells, the roles of different acyl species of CL in BTHS
remain unclear.
2. Barth syndrome (BTHS)
BTHS is a life-threatening, X-linked disorder that was first characterized in a large
Dutch family by pediatric neurologist Peter Barth in 1983. The clinical pattern presents in
infants with dilated cardiomyopathy, skeletal myopathy, and neutropenia (Barth et al.
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1983). The phenotypes are associated with abnormal mitochondrial structure and
respiratory chain abnormalities. (Barth et al. 1983). Bione et al. mapped the gene
responsible for BTHS to the Xq28 region, the G4.5 point of which was later cloned,
sequenced, and identified as “tafazzin” (Bione et al. 1993; Bione et al. 1996). The
acyltransferase activity of tafazzin and its role in altering phospholipid composition in
BTHS mitochondria was suggested in 1997 and subsequently characterized in patients
and disease models (Neuwald 1997; Schlame et al. 2002; Vreken et al. 2000).
A complicating feature of BTHS is that patients exhibit a board range of clinical
abnormalities. The clinical presentations vary substantially even among patients that
share the same tafazzin mutation (Johnston et al. 1997). Examples include partial
phenotypes, such as isolated neutropenia and lack of cardiomyopathy in ~6% of the
patients (Kelley et al. 1991; Roberts et al. 2012). This suggests that treatment outcomes
are influenced by physiological factors that remain to be identified. To date, the pathology
of the disease remains unclear, and it cannot be cured with current treatments.
3. BTHS models from yeast to human
The budding or Baker’s yeast, Saccharomyces cerevisiae, is a widely used
eukaryotic model organism. It is fast-growing, nonpathogenic, and, more importantly,
easy to manipulate genetically. In 1996, the yeast genome was the first eukaryotic
genome to be completely sequenced (Galibert et al. 1996). It has since provided valuable
information for the understanding of individual genes in cellular functions and diseases.
As an excellent model for studying CL, the deletion of any CL biosynthetic or remodeling
gene is not lethal to yeast. This feature enables a complete depletion of CL from the cells
by knocking out a single gene, the CL synthase gene CRD1 (previously known as CLS1)
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(Chang et al. 1998b; Jiang et al. 1997; Tuller et al. 1998). A mutant lacking the yeast
tafazzin, taz1Δ, was the first eukaryotic BTHS model. It is characterized by increased
MLCL levels, decreased total and unsaturated CL levels, and decreased growth, lifespan,
and mitochondrial function in medium containing ethanol as the sole carbon source (Gu
et al. 2004; Ye et al. 2014). The relative ease of genetic manipulation of yeast enables
high-throughput, large-scale genetic screening. Using synthetic genetic array (SGA)
analysis of crd1Δ cells, Raja et al. revealed important roles of CL in acetyl-CoA and
pyruvate dehydrogenase (PDH) synthesis bypass (Raja et al. 2017). An SGA screen with
the CL phospholipase mutant, cld1Δ, was carried out in the studies reported in this
dissertation and is described in Chapter 4.
The Taz-/- fly has also proven to be an important model for BTHS research. The
high content of mitochondria in its specialized flight muscles makes it advantageous for
studying mitochondrial dysfunction (Sohal 1976; Xu et al. 2006b). Xu et al. created a
mutant resulting from imprecise excision of a P-element inserted upstream of the tafazzin
gene ORF, which results in defects in tafazzin gene expression, reduced CL levels and
diversification, and decreased flying ability (Xu et al. 2006b).
A mouse TAZ-KO C2C12 myoblast strain generated by Lou et al. using the
CRISPR/Cas9 system exhibits increased MLCL/CL, elevated reactive oxygen species
(ROS), decreased mitochondrial membrane potential, aberrant respiration, and
deficiency in differentiation (Lou et al. 2018a). Decreased PDH activity and abnormal TCA
cycle metabolism also have been shown in this cell line (Li et al. 2019). Due to the
availability of congenic controls and relatively inexpensive maintenance, TAZ-KO cells
are an excellent model for studying bioenergetic and metabolic defects and muscle
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dysfunction in BTHS. Both TAZ-knockdown (TAZ-KD) and TAZ-KO mice have been
constructed, which could be used for studying pathological changes in skeletal and
cardiac muscles. The first TAZ-KD mouse models were established recently (Acehan et
al. 2011b; Soustek et al. 2011). Cadalbert et al. constructed a conditional TAZ-KO mouse
which was used for studying male germ cell meiosis and spermatogenesis (Cadalbert et
al. 2015). While mouse models enable studies of tissues and spermatogenesis and are
highly physiologically relevant to BTHS, they are relatively expensive and laborious to
handle.
Lymphoblast lines, induced pluripotent stem cells (iPSCs), and cardiac tissues
from or generated from patients exhibit similar mitochondrial defects such as abnormal
mitochondrial morphology and mass and decreased mitochondrial membrane potential
(Dudek et al. 2013; Xu et al. 2005). While studying the disease in cells that are directly
derived from patients is an advantage, the disadvantage is the lack of congenic controls
for lymphoblasts and cardiac tissues.
4. Perturbed bioenergetics and metabolism in BTHS models
The TCA cycle is a metabolic hub in eukaryotic cells. The bioenergetic role of the
cycle includes the oxidation of acetyl-CoA generated from carbohydrates, fats, and
proteins to generate NADH. TCA cycle intermediates also play a biosynthetic role in the
synthesis of nonessential amino acids, glucose, and fatty acids. Due to the importance of
the TCA cycle, a surplus pool of TCA cycle intermediates is maintained during periods of
high or low energy consumption (Owen et al. 2002).
It has been shown that the loss of CL in yeast cells (crd1Δ) leads to decreased
synthesis of acetyl-CoA (Raja et al. 2017) and reduced activities of the TCA cycle
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enzymes aconitase and succinate dehydrogenase (Patil et al. 2013). Li et al. showed that
TAZ-KO C2C12 cells have decreased pyruvate dehydrogenase (PDH) activity and
abnormal TCA cycle metabolism, characterized by decreased [U-13C] glucose flux to
acetyl-CoA, citrate/isocitrate, succinate, fumarate, malate, glutamate, and aspartate (Li
et al. 2019). These findings may explain some of the metabolic hallmarks of BTHS,
including altered plasma amino acid levels, most notably arginine deficiency. Raja et al.
showed that the yeast crd1Δ mutant exhibits synthetic lethality with mutants in the TCA
cycle, pyruvate carboxylase, retrograde (RTG) pathway, and glyoxylate cycle (Raja et al.
2019a). The mutant also exhibits glutamate auxotrophy and decreased levels of
glutamate. Oleate supplementation rescues growth defects, suggesting that TCA cycle
deficiency in CL mutants necessitates activation of anaplerotic pathways to replenish TCA
cycle intermediates (Raja et al. 2019a)
The ETC carries out oxidative phosphorylation (OXPHOS) to generate ATP.
Phenotypes in BTHS, including reduced mitochondrial membrane potential, decreased
OCR, and increased sensitivity to oxidative stress, are associated with CL-dependent
ETC abnormalities. CL supports optimal ETC function by several mechanisms. Among
these is direct binding to proteins and protein complexes. Chromatographic and
crystallographic studies have shown that CL physically binds with complex I, complex III,
complex IV, and ATPase, and is required for their functions (Eble et al. 1990; Fry and
Green 1981; Lange et al. 2001; Ozawa et al. 1982; Robinson 1993). CL also functions in
organizing supercomplexes and supramolecular structures. As a "soft" component of
supercomplexes, CL is crucial in increasing supercomplex association (Acehan et al.
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2011a; K. Pfeiffer et al. 2003; Ren et al. 2014; M. Zhang et al. 2002). The supramolecular
organization of ATP synthase also relies on CL (Acehan et al. 2011a).
Lactic acidosis as a result of increased glycolysis and anaerobic fermentation is a
common phenotype in mitochondrial diseases. This phenotype is also observed in many
BTHS patients and, together with 3-methyglutaconic aciduria, is considered an early
biochemical marker for the disease (Ferri et al. 2013). PDH activity, TCA cycle, OXPHOS,
glycolysis, and fermentation are all essential metabolic processes that are tightly linked
to the redox balance of NAD+ and NADH (Fig. 1-3). The dehydrogenases and
oxidoreductases in glycolysis and the TCA cycle reduce NAD+ to NADH, which is oxidized
during OXPHOS for ATP production. As the TCA cycle and the ETC require NAD+ and
NADH, respectively, an optimal NAD+/NADH ratio is crucial for mitochondrial metabolism
(Stein and Imai 2012). In addition to directly affecting TCA cycle function by regulating
dehydrogenases in the TCA cycle, the NAD+/NADH ratio alters TCA cycle metabolism by
regulating PDH activity as well. The oxidation of pyruvate to acetyl-CoA, carried out by
PDH, is accompanied by the reduction of NAD+; therefore, a high NAD+/NADH ratio is
expected to promote its activity and vice versa based on the redox switch/redox coupling
hypothesis (Cerdan et al. 2006). Pyruvate dehydrogenase kinase (PDK), which mediates
the inhibitory phosphorylation of PDH, is also activated by a decreased NAD+/NADH ratio
(Park et al. 2018). The redox of NAD+ and NADH also accompanies the interconversion
of pyruvate and lactate, which is carried out by lactate dehydrogenase (LDH). An
increased NAD+/NADH ratio favors the oxidation of extracellular lactate in the LDH
equilibrium (Cerdan et al. 2006). Increased fermentation and NAD(H) metabolism are
studied in CL-deficient models in Chapter 2 and Chapter 3, respectively.
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Figure 1-3. Summary of NAD(H)-dependent metabolic processes in the context
of this dissertation.
Adh, alcohol dehydrogenase; Nde1, 2, OMM dehydrogenase; Ndi1, IMM NADH
dehydrogenase; LDH, (mammalian) lactate dehydrogenase; complex I, (mammalian)
NADH dehydrogenase. Enzyme or protein complexes are highlighted in green (yeast)
or orange (mammalian) circles.
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5. Project outline
This dissertation research attempted to elucidate mechanisms underlying the
metabolic and bioenergetic defects exhibited in CL-deficient cells. In addition,
mitochondrial physiology was studied in the absence or presence of oxidizable CL. A
large-scale, high-throughput genetic screen for mutants that genetically interact with the
yeast enzyme that initiates CL remodeling, CL phospholipase Cld1, was described as
well, pointing out new cellular pathways that may be functionally important for Cld1 or CL
remodeling.
The studies in Chapter 2 demonstrate that fermentation is essential for CLdeficient yeast cells. The fermentation pathway is upregulated in the yeast CL mutant
crd1Δ during heat stress when grown in galactose. Loss of function of the fermentation
pathway is lethal to the mutant. Promoting fermentation by supplying pyruvate and
acetaldehyde partially rescues the temperature sensitivity of crd1Δ in a fermentation
pathway-dependent manner. The findings suggest that increased glycolysis/fermentation
supports the growth of crd1Δ by maintaining the NAD+ redox balance.
In the studies of Chapter 3, defects in NAD(H) metabolism are characterized in
several BTHS models, including yeast crd1Δ, TAZ-KO C2C12 myoblast cells, and Taz889
Drosophila. Supplementation of NAD precursors nicotinamide riboside (NR) or
nicotinamide mononucleotide (NMN) improves mitochondrial function in these models by
increasing the NAD+/NADH ratio.
Chapter 4 describes a study of how ΔΨm responds to stress induced by oxidants,
complex inhibitors, and mutations, in the absence or presence of oxidizable CL. An
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innovative method was developed to simulate mammalian ischemia-reperfusion.
Additionally, the effect of SS-31 on mitochondrial function was tested.
In Chapter 5, a synthetic genetic array (SGA) with a query strain containing the
mutation cld1Δ is described, with the purpose of finding potential genes and pathways
that are functionally redundant with the yeast CL-specific phospholipase. Genes that
function in protein sorting, sphingolipid metabolism, and tRNA wobbling were discovered
and discussed in this chapter.
This dissertation describes exciting findings regarding the metabolic and
bioenergetic defects resulting from CL-deficiency and new insights into the functional
significance of CL remodeling.
This dissertation describes exciting findings regarding the metabolic and
bioenergetic defects resulting from CL-deficiency and new insights into the functional
significance of CL remodeling. Many interesting questions remain and a novel model that
describes complex inter-relationship between NAD+ and CL-associated metabolic
abnormalities are discussed in Chapter 6.
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CHAPTER 2
PERTURBATION OF CARDIOLIPIN SYNTHESIS AFFECTS
GLYCOLYSIS/FERMENTATION DURING GROWTH IN GALACTOSE
INTRODUCTION
As discussed in Chapter 1, cardiolipin (CL) is the mitochondrial signature
phospholipid and is required for optimal mitochondrial function. The importance of
studying CL is underscored by the rare, infantile-onset, severe mitochondrial disease
Barth syndrome (BTHS), which is caused by variants in the CL remodeling gene tafazzin
(TAZ) (Barth et al. 1983; Bione et al. 1993; Bione et al. 1996). Disruption of TAZ results
in deficiencies in CL, accumulation of monolysocardiolipin (MLCL) and decreased
mitochondrial function (Bione et al. 1993; Bione et al. 1996; Schlame et al. 2002;
Valianpour et al. 2005; Vreken et al. 2000). Lactic acidosis and 3-methyglutaconic
aciduria (3-MGA) are metabolic hallmarks of the disease (Ferri et al. 2013; Kelley et al.
1991). Lactic acidosis is associated with metabolic decompensation, the extent of which
is correlated with the severity of the clinical course of BTHS (Donati et al. 2006; Ferri et
al. 2013). It has been shown that acute metabolic decompensation is prone to accompany
severe heart failure occurs and could cause sudden death in BTHS (Donati et al. 2006;
Yen et al. 2008).
Lactic acidosis results from increased glycolysis/fermentation. Glycolysis via the
Embden-Meyerhof-Parnas (EMP) pathway converts glucose-6-phosphate (G-6-P) to
pyruvate, the process of which is accompanied by the reduction of NAD+ to NADH and
production of ATP (Fig. 2-1). Two ATP molecules are generated from each glucose
molecule that is converted to pyruvate. Pyruvate may be converted enzymatically to
several products and thus has multiple fates: acetyl-CoA, which enters the TCA cycle and
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supports fatty acid synthesis; oxaloacetate (OAA), which acts as a TCA cycle
intermediate and supports gluconeogenesis; and lactate (common to all eukaryotes) or
ethanol (only found in yeast), which is the product of fermentation.

Under aerobic

conditions, the oxidation/dehydrogenation steps in the TCA cycle generate NADH or
FADH2, which are oxidized by the electron transport chain (ETC) during oxidative
phosphorylation (OXPHOS), producing ATP. Under anaerobic conditions, fermentation is
upregulated, and pyruvate is reduced to lactate or ethanol, regenerating NAD+ from
NADH. Fermentation is also found to increase in mammalian cells with mitochondrial
dysfunction. It is widely accepted that decreased mitochondrial ATP production results in
increased glycolysis for generating energy. Additionally, the fermentation pathway
regenerates NAD+ from NADH to enable the continuation of glycolysis (T. Pfeiffer and
Morley 2014). Lactic acidosis is the most recognized metabolic abnormality in patients
with mitochondrial disorders (Jackson et al. 1995; Koenig 2008). The accumulated lactate
observed in BTHS patients’ blood and urine and in mammalian TAZ knockout (TAZ-KO)
models suggests an association between CL and upregulated fermentation (Ferri et al.
2013; Lou et al. 2018a; Powers et al. 2013).
The yeast Saccharomyces cerevisiae has been an excellent model for studying
mitochondrial dysfunction because its fermenting capacity allows it to tolerate the loss of
OXPHOS activity (Lasserre et al. 2015). The availability of yeast CL mutants has enabled
rigorous genetic and biochemical explorations of CL biosynthesis and remodeling and
their roles in important cellular processes, including bioenergetics. The high fermenting
capacity of yeast is associated with the Crabtree effect, which refers to the preferential
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Figure 2-1. Glucose and galactose metabolism in the yeast S. cerevisiae.
When a glucose molecule is converted to two pyruvate molecules during glycolysis, four
ATP molecules are generated and two are consumed. In the yeast S. cerevisiae, glucose
represses OXPHOS, which is carried out by the electron transport chain (ETC), even
under aerobic conditions. Instead, glucose is preferably used for the production of
ethanol (EtOH) (fermentation) (De Deken 1966; Marroquin et al. 2007). Two ATP
molecules are generated from each glucose molecule that is converted to pyruvate. To
enter glycolysis, galactose is first converted to glucose-6-phosphate (G-6-P) by the Leloir
pathway. The conversion of galactose to galactose-1-phosphate (Gal-1-P) consumes
one ATP. The further conversion of Gal-1-P to glucose-1-phosphate (G-1-P) is
accompanied by the interconversion of UDP-glucose (UDP-G) and UDP-galactose
(UDP-Gal). This process consumes one UTP, the generation of which costs two ATP
molecules (Holden et al. 2003; J. H. Lee et al. 2010). The conversion of G-6-P to
pyruvate generates three ATP molecules. Therefore, the glycolytic yield of ATP from
galactose is zero. F-6-P, fructose-5-phosphate; F-1,6-P, fructose-1,6-biphosphate;
GADP, glyceraldehyde-3-phophate; DHAP, dihydroxyacetone phosphate; 1,3-PG, 1,3biphosphoglycerate; 3-PG, 3-phosphoglycerate; 2-PG, 2-phosphoglycerate; PEP,
phosphoenolpyruvate; Adh, alcohol dehydrogenase; EtOH, ethanol; Ac, acetate; Ac-P,
acetate-phosphate.
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use of glucose for fermentation even in aerobic conditions (De Deken 1966; Marroquin et
al. 2007). The presence of glucose has been shown to repress respiration at the
transcriptional, post-transcriptional, and post-translational levels (Kayikci and Nielsen
2015). Despite that glycolysis/fermentation has a much lower ATP yield when compared
to OXPHOS (two vs. approximately 18 per glucose), the energy produced by glycolysis
is sufficient for the growth of ρ0 cells, which has lost mitochondrial DNA (mtDNA)
(Ferguson and von Borstel 1992; Woo and Poyton 2009). Therefore, it is intriguing to ask
if mitochondrial defects lead to increased fermentation in fermentable medium. Although
increased ethanol production has been observed in cytoplasmic petite mutants (Bacila et
al. 1978), this may not be the case when mitochondrial dysfunction is less severe, such
as in the yeast CL synthase mutant crd1Δ.
In addition to glucose, galactose is a commonly used fermentable carbon source
in cell culture. To be used in glycolysis, galactose is first converted to G-6-P by the Leloir
pathway. As seen in Fig. 2-1, the conversion of galactose to galactose-1-phosphate (Gal1-P) consumes one ATP. The conversion of Gal-1-P to glucose-1-phosphate (G-1-P) is
accompanied by the interconversion of UDP-glucose (UDP-G) and UDP-galactose (UDPGal). This process requires UTP, generation of which from UMP consumes two ATP
molecules (Holden et al. 2003; J. H. Lee et al. 2010). Therefore, three ATP molecules are
consumed for each galactose molecule converted to G-6-P. Because three ATP
molecules are generated from the conversion of G-6-P to pyruvate, the glycolytic yield of
ATP from galactose is zero. It is worth mentioning that yeast ρ0 cells, which are unable to
respire via cyanide-sensitive oxidative phosphorylation (OXPHOS), can still grow on
galactose medium, likely due to cyanide-resistant respiration (CRR) that is conferred by
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the alternative oxidase (AOX), which bypasses complexes III and IV (Veiga et al. 2003;
Woo and Poyton 2009). However, a medium containing galactose as the sole carbon
source cannot sustain growth of ρ0 cells that do not have the AOX, e.g., a human breast
cancer cell line that has lost mtDNA (Delsite et al. 2002). Nevertheless, it is intriguing to
determine if mitochondrial defects in yeast result in increased glycolysis/fermentation
when OXPHOS is not inhibited by glucose.
In this study, I report that yeast cells lacking CL exhibit increased ethanol
production in galactose. The fermentation pathway is essential for the growth of crd1Δ.
Importantly, increasing fermentation by supplying substrates to the pathway benefits
crd1Δ without providing glycolytically generated ATP. The findings provide novel insights
into the link between CL deficiency and fermentation in yeast cells, which may shed light
on the metabolic alterations and mechanisms of BTHS.
MATERIALS AND METHODS
Yeast Strains and Growth Media
The yeast S. cerevisiae strains used in this study are listed in Table 2-1. Adh1Δ
(MATα) and double mutants were obtained by tetrad dissection.
Synthetic complete (SC) medium contained adenine (20.25 mg/L), arginine (20 mg/L),
histidine (20 mg/L), leucine (60 mg/L), lysine (200 mg/L), methionine (20 mg/L), threonine
(300 mg/L), tryptophan (20 mg/L), uracil (20 mg/L), and yeast nitrogen base without amino
acids (Difco). Glucose (2%) or galactose (2%) was used as carbon source.
Spotting Assay
Cells were grown in SC-glucose medium to the stationary phase at 30°C, washed
with sterile water, and diluted to an A550 of 0.5. 5 μl aliquots of a series of 10- or 5-fold
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Table 2-1. Strains used in this study
Strain

Genotype

Source

BY4741

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0

Invitrogen

crd1Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
crd1Δ::KanMX6

Invitrogen

adh1Δ

MATa/α his3Δ1/his3Δ1 leu2Δ0/leu2Δ0
met15Δ0/MET15 LYS2/lys2Δ0 ura3Δ0/ura3Δ0

Dharmacon

adh1Δ

MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 adh1Δ::KanMX6

This study

adh1Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
adh1Δ::KanMX6

This study

adh2Δ

MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 adh2Δ::KanMX6

Dharmacon

adh2Δ

MATa his3Δ1 leu2Δ0 ura3Δ0 adh2Δ::KanMX6

This study

adh3Δ

MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 adh3Δ::KanMX6

Dharmacon

adh3Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
adh3Δ::KanMX6

This study

adh4Δ

MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 adh4Δ::KanMX6

Dharmacon

adh4Δ

MATa his3Δ1 leu2Δ0 ura3Δ0 adh4Δ::KanMX6

This study

adh5Δ

MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 adh5Δ::KanMX6

Dharmacon

adh5Δ

MATa his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 adh5Δ::KanMX6

This study

crd1Δadh1Δ

MATa his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 crd1Δ::KanMX6

This study

adh1Δ::KanMX6
crd1Δadh2Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
crd1Δ::KanMX6

This study

adh2Δ::KanMX6
crd1Δadh3Δ

MATa his3Δ1 leu2Δ0 ura3Δ0 crd1Δ::KanMX6

This study

adh3Δ::KanMX6
crd1Δadh4Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
crd1Δ::KanMX6

This study
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adh4Δ::KanMX6
crd1Δadh5Δ

MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0
crd1Δ::KanMX6
adh5Δ::KanMX6

This study
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Table 2-2. Real-time PCR primers used in this study
Gene

Primers

Sequence (5’ to 3’)

Source

ACT1

Forward

GATTCTGAGGTTGCTGCTTTG

(Raja et al.
2019a)

ADH1

ADH2

ADH3

ADH5

Reverse

TTGACCCATACCGACCATGA

Forward

CCAAGTCGTCAAGTCCATCTC

Reverse

TCTGGCGAAGAAGTCCAAAG

Forward

GTACTGTTGTCTTGGTTGGTTTG

Reverse

GTAAGAGCCGACAATGGAGATAG

Forward

CCGCTAACGCCTACGTTAAA

Reverse

AGTCTAAGGCTTCTCTCGTATCA

Forward

CGTTGGATCTTGTGTTGGAAATAG

Reverse

AGCTAAGTGGATCGGAGATTTG

This study

(Ye et al. 2014)

This study

This study
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dilutions were spotted onto the indicated plates and incubated at the indicated
temperatures.
Measurement of Ethanol
Cells were grown to the logarithmic phase at A550 of 0.5 to 1, collected by
centrifugation, and washed twice with sterile water. Following resuspension in fresh
medium, the samples were diluted with fresh medium to A550 of 0.5. After the indicated
hours of incubation at high temperature, 1 ml of culture was transferred quickly to a 1.7
ml centrifuge tube and centrifugated at maximum speed, 4°C, for 1 min. 400 μl of
supernatant were transferred to a new tube. To measure ethanol in the supernatant, a
colorimetric assay kit (Sigma) was used according to the manufacturer’s manual.
Real-Time Quantitative PCR (RT-qPCR) Analysis
Mid-logarithmic phase cells grown at 30°C were stressed for two hours at 38°C and
harvested at 4°C. Total RNA was extracted using hot phenol (Kohrer and Domdey 1991)
and purified using the Rneasy Mini Plus kit (Qiagen, Valencia, CA). A first-strand cDNA
synthesis kit (Roche Applied Science) was used for complementary DNA (cDNA)
synthesis. RT-qPCR was performed using Brilliant III Ultra-Faster SYBR Green qPCR
Master Mix (Agilent Technologies, Santa Clara, CA). Two technical replicates each of
three biological replicates were included for each reaction. RNA levels were normalized
to ACT1. Relative values of mRNA transcripts are shown as fold change relative to the
indicated controls. The primers for RT-qPCR are listed in Table 2-2. Primer
concentrations were optimized to ensure efficiencies between 95% and 105% and not 5%
higher or lower than the efficiency of ACT1 primers.
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Statistical Analysis
All statistical analyses were performed using two-tailed unpaired Student’s t test
(n.s., P >0.05; *, P≤ 0.05; **, p≤0.01; ***, p≤0.001; ****, p≤0.0001).
RESULTS
Yeast crd1Δ increases ethanol production during heat stress in galactose.
As addressed in the introduction, mitochondrial defects may result in increased
glycolysis/fermentation to compensate for decreased ATP production in mitochondria and
to regenerate NAD+ from NADH (T. Pfeiffer and Morley 2014). The yeast S. cerevisiae
preferably ferments glucose for energy production regardless of the availability of oxygen
(De Deken 1966; Marroquin et al. 2007). In galactose, yeast cells rely on OXPHOS for
energy production. Therefore, an ETC defect such as that characterized in crd1Δ may
have a higher impact on fermentation in galactose compared to that in glucose.
To assess the levels of fermentation in WT and crd1Δ in glucose and galactose
under mitochondrial stress, I measured the ethanol produced during two- and five-hour
heat stress. As seen in Fig. 2-2A, WT and crd1Δ in the mid-logarithmic phase produced
similar levels of ethanol in glucose (Fig. 2-2A), suggesting that the mitochondrial defect
of crd1Δ does not result in upregulated fermentation. However, crd1Δ produced a
significantly higher amount of ethanol in galactose medium (Fig. 2-2B). Considering that
no net ATP is generated from converting galactose to ethanol, it is unlikely that the
increased fermentation compensates for the decreased ATP production during OXPHOS;
more likely, it compensates for the decreased regeneration of NAD+ from NADH at the
ETC.
The yeast tafazzin mutant taz1Δ, which accumulates MLCL and contains
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Figure 2-2. crd1Δ increases ethanol production in response to heat stress.
Cells were grown at 30ºC in SC-glucose medium to the mid-logarithmic phase, washed
twice with sterile water, resuspended in fresh SC-glucose (A) or galactose (B&C)
medium, and diluted to an A550 of 0.5. After shaking incubation for two or five h at 39ºC,
supernatant from 1 ml culture was collected by centrifugation. Ethanol contained in the
medium was measured as described in Materials and Methods. Data shown are mean ±
S.D. (n=4). Cells were grown at 30ºC in SC-glucose medium to the mid-logarithmic
phase,
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decreased total CL levels, exhibits less severe mitochondrial dysfunction than does crd1Δ
(Gu et al. 2004). Unlike crd1Δ, which shows decreased growth on media that contain
various carbon sources at high temperatures (Jiang et al. 2000; Patil et al. 2013), the
growth defect of taz1Δ has only been identified in medium that contains the respiratory
carbon source ethanol (Gu et al. 2004), consistent with a relatively mild mitochondrial
defect. In agreement with these findings, the levels of ethanol produced by taz1Δ were
similar to those of WT during five-hour heat stress in galactose medium (Fig. 2-2C),
suggesting that the OXPHOS activity of taz1Δ is not significantly affected under this
condition.
Taken together, these findings suggest that the mitochondrial defect of crd1Δ
results in increased fermentation/glycolysis in galactose, potentially to increase the
regeneration of NAD+ from NADH. A less severe mitochondrial defect such as that in
taz1Δ does not result in increased fermentation.
The fermentation pathway is required for optimal growth of crd1Δ in galactose
medium.
The increased ethanol production by crd1Δ in galactose (Fig. 2-2B) suggests an
important role of the fermentation pathway in the mutant. The reduction of acetaldehyde
to ethanol requires alcohol dehydrogenase (ADH). Among the 13 ADHs that have been
characterized in S. cerevisiae, the cytosolic Adh1 is the major enzyme responsible for
converting acetaldehyde to ethanol during glycolysis/fermentation (de Smidt et al. 2008;
Leskovac et al. 2002). Therefore, the activity of Adh1 may be essential for the survival of
crd1Δ.
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To test this possibility, I deleted ADH1-5 from crd1Δ to determine if crd1Δ is
synthetically lethal with loss of ADH activity. Of the five ADH mutants, only adh1Δ
exhibited severely decreased growth on glucose (Fig. 2-3A), suggesting the predominant
role of Adh1 in the fermentation pathway. The double mutant crd1Δadh1Δ exhibited a
significant growth defect on galactose compared to controls (Fig. 2-3A), suggesting that
Adh1 activity is required for the survival of crd1Δ. In agreement, deletion of other ADH
genes (ADH2-5) from crd1Δ did not exacerbate the growth defect of the mutant (Fig. 23A). These findings indicate that the function of Adh1 is critical for the growth of crd1Δ in
galactose.
ADH genes are highly regulated at the transcriptional level (de Smidt et al. 2008).
To determine if the increased ethanol production by crd1Δ is correlated with upregulation
of the fermentation pathway, the mRNA levels of ADH genes were determined prior to
and after two-hour heat stress. As seen in Fig. 2-3B, the expression of ADH1 increased
significantly in all strains, by five- to seven- fold, in response to heat stress. This is in
agreement with the predominant role of Adh1 in the fermentation pathway. To a much
lesser extent, the mRNA level of ADH3 increased as well (Fig. 2-3B). However, WT and
crd1Δ expressed similar levels of ADH1 and ADH3 (Fig. 2-3B), suggesting that increased
ethanol production in crd1Δ is not attributed to the upregulation of ADH1 or ADH3 at the
transcriptional level. Both crd1Δ and taz1Δ showed increased expression of ADH2 (Fig.
2-3B). However, crd1Δ produced significantly higher levels of ethanol during heat stress
than taz1Δ (Fig. 2-2C), suggesting that the increased expression of ADH2 is not the likely
cause of increased ethanol production. Therefore, the differences in ethanol production
observed in Fig. 2-2C may result from regulation at the levels of translation or enzymatic
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Figure 2-3. The fermentation pathway is essential for the optimal growth of crd1Δ.
(A) WT, crd1Δ, adhxΔ (x=1, 2, 3, 4, 5), and crd1ΔadhxΔ cells were pre-cultured in SCglucose medium to the stationary phase and diluted to an A550 of 0.5. 5 μL aliquots of a
series of 10-fold dilutions were spotted on SC-glucose or galactose plates and
incubated at 39 ºC for three days. (B) WT, crd1Δ, and taz1Δ were grown to the midlogarithmic phase, mRNA levels of the indicated genes before and after 2 h heat stress
were determined by RT-PCR as described in Materials and Methods. The values shown
represent the fold change relative to expression of ACT1 in WT cells before heat stress
and are mean ± S.D. (n=3; three biological replicates and two technical replicates)
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activity (see Discussion).
Increasing the activity of the fermentation pathway increases the growth of crd1Δ
in galactose.
Based on the finding that the fermentation pathway is critical for the growth of
crd1Δ in galactose, I hypothesized that further increasing the activity of this pathway
would improve the growth of crd1Δ in response to stress. To test the hypothesis, the
substrates of this pathway, acetaldehyde and pyruvate, were supplied in medium to
determine if they rescue the temperature sensitivity of crd1Δ. To increase the resolution
of the spotting results, five-fold instead of 10-fold serial dilutions were used in
thisexperiment.

As seen in Fig. 2-4, supplementation of acetaldehyde or pyruvate

rescued the temperature sensitivity of crd1Δ, but not when the ADH1 gene is lacking.
The findings suggest that the rescue of crd1Δ by acetaldehyde or pyruvate relies on the
function of Adh1.
DISCUSSION
This study shows for the first time that yeast cells lacking CL increase fermentation
in galactose and that the fermentation pathway is critical for the survival of the CL mutant
crd1Δ. Importantly, the findings suggest that increasing the activity of the fermentation
pathway rescues the temperature sensitivity of CL-deficient cells without increasing
glycolytic energy production. The role of CL in OXPHOS has been well documented (Ren
et al. 2014). However, it has only recently been determined that CL is required for TCA
cycle function, suggesting a critical role of CL in cellular metabolism (Patil et al. 2013;
Raja et al. 2017). Increased lactate in BTHS patients and TAZ-KO mouse models
suggests an association between CL and upregulated fermentation in mammalian cells
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Figure 2-4. Acetaldehyde and pyruvate rescue the temperature sensitivity of crd1Δ
in an ADH1-dependent manner.
Cells were pre-cultured in SC-glucose medium to the stationary phase, washed and
resuspended in sterile water, and diluted to an A550 of 0.5. 5 μL aliquots of a series of fivefold dilutions were spotted on SC-galactose medium containing supplementations as
indicated. Plates were incubated at 38 ºC for three days.
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(Ferri et al. 2013; Lou et al. 2018a; Powers et al. 2013). The current study utilizes yeast
to further explore the effect of CL-associated mitochondrial defects on fermentation and
demonstrates that CL-deficient cells exhibit increased fermentation in galactose. The
findings futher suggest that glycolysis/fermentation may play a greater role in NAD+
regeneration than in ATP production.
Increased fermentation is commonly associated with anaerobic conditions and
mitochondrial dysfunction. The yeast S. cerevisiae ferments glucose regardless of oxygen
availability (Crabtree effect) and inhibits OXPHOS in the presence of glucose (De Deken
1966; Marroquin et al. 2007). Because the ETC activity is not in demand when cells are
grown in glucose, ETC defects to a certain level are not expected to result in a further
increase in fermentation. Herein, I report that crd1Δ does not increase fermentation during
heat stress (Fig. 2-2A), indicating that the slightly decreased OXPHOS function in crd1Δ
is sufficient to support growth without increasing glycolysis/fermentation. However, crd1Δ
exhibits increased ethanol production consistent with increased glycolysis/fermentation
in galactose (Fig. 2-2A). Because the net yield of ATP from galactose to ethanol is zero,
the increased glycolysis/fermentation may be required to regenerate NAD+ from NADH,
rather than to increase ATP production. ETC activity is decreased in crd1Δ (Jiang et al.
2000). Increasing fermentation may compensate for the decrease in NADH oxidation by
the ETC. A balanced NAD+/NADH redox not only enables the continuation of glycolysis
but also regulates a large number of oxidation reactions that are carried out by
dehydrogenases, including several in the TCA cycle (Xiao et al. 2018). The finding that
ethanol production is not increased in taz1Δ (Fig. 2-2C) suggests that the NAD+/NADH
redox is well maintained by the relatively high ETC activity in taz1Δ when compared to
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that in crd1Δ. Indeed, unlike crd1Δ, which exhibits growth defects in media containing
various carbon sources such as glucose, glycerol, galactose, and ethanol, the growth
defect of taz1Δ has only been observed in medium that contains the strictly respiratory
carbon source ethanol, consistent with a minor mitochondrial dysfunction when compared
to that of crd1Δ (Gu et al. 2004; Jiang et al. 2000; Koshkin and Greenberg 2000, 2002;
Luévano-Martínez et al. 2015; Patil et al. 2013).
During yeast fermentation, reduction of acetaldehyde to ethanol is catalyzed by
ADH, the activity of which requires the oxidation of NADH. Of the ADH enzymes in yeast,
only Adh3 is localized in mitochondria; the others are cytosolic enzymes (de Smidt et al.
2008). Cytosolic Adh1 is the major enzyme that reduces acetaldehyde to ethanol during
glycolysis/fermentation (de Smidt et al. 2008; Leskovac et al. 2002). In agreement, growth
of adh1Δ but not that of other ADH mutants is affected severely in glucose (Fig. 2-3A).
Deletion of ADH1 is deleterious to crd1Δ in galactose (Fig. 2-3A), suggesting that the
fermentation pathway is critical for the survival of cells lacking CL and that the increased
fermentation by crd1Δ (Fig. 2-2B) likely is required for the cells. Indeed, supplying
intermediates of the fermentation pathway, pyruvate and acetaldehyde, rescues the
temperature sensitivity of crd1Δ (Fig. 2-4). Again, because the conversion of galactose to
pyruvate does not generate ATP, increasing fermentation does not contribute to ATP
production. Instead, increased ADH activity could regenerate NAD+ from NADH,
compensating for the decreased NADH oxidation at the ETC of the CL-deficient cells. In
agreement, the yeast Candida albicans ADH1 null mutant has a decreased NAD+/NADH
ratio (Song et al. 2019).
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The ADH genes are highly regulated at the transcriptional level (Arigo et al. 2006;
de Smidt et al. 2008). Increased expression of ADH genes results in increased ethanol
production (Dahiya et al. 2016). However, in the current study, the mRNA levels of ADH
genes (Fig. 2-3B) in WT, crd1Δ, and taz1Δ do not correlate with their differences in
ethanol production (Fig. 2-2B). Specifically, increased ethanol production by crd1Δ (Fig.
2-2B) is not reflected in increased expression of ADH genes. The redox switch/redox
coupling hypothesis by Cerdan et al. suggests that a decreased NAD+/NADH ratio favors
the reduction of pyruvate to lactate in the LDH equilibrium (Cerdan et al. 2006). Similarly,
a decreased NAD+/NADH ratio in crd1Δ could explain the increased ethanol production.
Interestingly, ADH has been shown to be regulated at the protein level by a trans-acting
regulatory element in Drosophila melanogaster and at the post-transcriptional level in
Aspergillus (King and McDonald 1987; Pateman et al. 1983). Whether yeast ADHs are
also regulated at post-transcriptional, translational, or post-translational levels has yet to
be determined.
Lactic acidosis, likely due to increased fermentation, is a metabolic hallmark of
BTHS (Ferri et al. 2013; Kelley et al. 1991; Kraut and Madias 2014). Abnormally
accumulated

lactic

acid

often

presents

with

metabolic

decompensation

and

cardiomyopathy (Donati et al. 2006; Ferri et al. 2013). The findings in this study suggest
that CL-deficient cells increase glycolysis/fermentation in order to maintain the NAD+
redox balance rather than to increase the production of ATP. The findings provide a new
direction to reduce accumulated lactic acid by improving a more balanced NAD+/NADH
ratio, the study of which may also shed light on other metabolic abnormalities in BTHS.
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CHAPTER 3
NAD SUPPLEMENTATION RESCUES MITOCHONDRIAL DEFECTS CAUSED BY
CARDIOLIPIN DEFICIENCY
INTRODUCTION
Nicotinamide adenine dinucleotide (NAD) is an important coenzyme in energy
metabolism. NAD+ is reduced to NADH by dehydrogenases in glycolysis, β-oxidation,
amino acid catabolism pathways, and the TCA cycle. NADH is then oxidized to NAD+ by
NADH dehydrogenase(s) at the electron transport chain (ETC) for the production of ATP.
Other enzymes that regenerate NAD+ from NADH include alcohol dehydrogenase (ADH)
(yeast) or lactate dehydrogenase (LDH) (mammalian) in the fermentation pathway and
D-β-hydroxybutyrate dehydrogenase in the ketogenesis pathway. The NAD+/NADH ratio
in cells is affected by the activities of the dehydrogenases and in turn regulates their
activities in oxidation/reduction reactions. For example, a low NAD+/NADH ratio favors
LDH to reduce pyruvate to lactate (fermentation), regenerating NAD+ from NADH.
Conversely, a high NAD+/NADH ratio favors LDH to oxidize lactate and reduce NAD+.
Under optimal conditions, a high NAD+/NADH ratio is maintained by the regeneration of
NAD+ from NADH by the ETC. A high NAD+/NADH ratio optimizes mitochondrial energy
production by promoting activities of the TCA cycle and the ETC. Alterations of the
NAD+/NADH ratio affect all metabolic pathways by regulating activities of the hydrate
transfer enzymes, and a decreased NAD+/NADH ratio has been associated with aging
and increased susceptibility of catabolic organs to oxidative stress (Elhassan et al. 2017).
The size of the NAD+ pool in cells is important in metabolism as well. Beyond function as
a coenzyme, NAD+ and its metabolites also act as substrates for enzymes such as sirtuins
and poly (ADP-ribose) polymerases (PARPs) (Bai 2015; Blander and Guarente 2004).
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The actions of sirtuins and PARPS affect mitochondrial function by regulating
mitochondrial biogenesis and mitochondrial DNA (mtDNA) replication and transcription
(Prolla and Denu 2014). The pool size of NAD+ is determined by biosynthesis,
consumption, and reduction of NAD+. Reduced NAD+ levels or NAD+/NADH ratios have
been reported in several models of aging (Massudi et al. 2012) and mitochondrial
diseases such as Leigh syndrome and heart failure (C. F. Lee et al. 2016; C. F. Lee et al.
2019).
NAD+ metabolism may be affected by metabolic abnormalities, including those in
cells with cardiolipin (CL) deficiency. CL supports the optimal function of the ETC by
physically binding with respiratory complexes I, III, IV, and ATPase (Eble et al. 1990; Fry
and Green 1981; Lange et al. 2001; Ozawa et al. 1982; Robinson 1993) and promoting
their association and supramolecular organization (Acehan et al. 2011a; K. Pfeiffer et al.
2003; Ren et al. 2014; M. Zhang et al. 2002). As the constitutive site for the oxidation of
NADH in aerobic cellular respiration, defects in ETC activity are expected to reduce the
NAD+/NADH ratio. A decreased NAD+/NADH ratio may explain the reduced pyruvate
dehydrogenase (PDH) activity (Li et al. 2019), decreased acetyl-CoA synthesis (Raja et
al. 2017), reduced flux from glucose to the TCA cycle (Li et al. 2019) that have been well
documented in CL-deficient cells. To maintain a balanced NAD+/NADH ratio, cells may
upregulate the fermentation pathway (Chapter 2) and/or ketogenesis pathway to
regenerate NAD+ from NADH. Indeed, the accumulation of plasma lactate (fermentation
product) and β-hydroxybutyrate (ketogenesis product) has been characterized in Barth
syndrome (BTHS), a genetic disorder of CL metabolism (Chapter 1) (Sandlers et al. 2016).
The metabolic defects in BTHS suggest that CL deficiency may cause an altered
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NAD+/NADH ratio and/or a decline in the NAD+ pool. Mitochondrial mass has been shown
to increase in BTHS lymphoblasts, likely to compensate for the loss of mitochondrial
function (Xu et al. 2005). As discussed above, NAD+ could be consumed to increase
mitochondrial biogenesis. The subsequent NAD+ limitation is likely to affect metabolic
efficiency (Canto et al. 2015; Stein and Imai 2012). In summary, CL deficiency may cause
abnormal NAD+ levels or redox balance, which may explain several metabolic changes
that have been characterized in CL synthase or tafazzin mutants.
Increasing NAD + levels and the NAD + /NADH ratio in models of aging and
mitochondrial disorders, especially by using NAD+ precursors, have been intensively
studied in recent years. NAD+ is synthesized de novo from tryptophan (Trp) by the
kynurenine pathway or from forms of vitamin B3 such as nicotinic acid (NA) and
nicotinamide (NAM) through salvage pathways (Fig. 3-1). However, Trp is considered to
be a poor NAD+ precursor. In humans, 1 mg of niacin (NA and NAM) is as efficient as 34
to 86 mg of Trp in supporting NAD+ synthesis (Horwitt et al. 1981). Despite that niacin is
an efficient NAD+ precursor, the use of it has been limited by unpleasant side effects
such as flushing and itching skin (Rolfe 2014). Nicotinamide riboside (NR) and
nicotinamide mononucleotide (NMN) do not cause flushing and are orally bioavailable,
making them preferable choices for clinical use (Conze et al. 2016; Trammell et al. 2016).
NR and NMN have been shown to improve mitochondrial and muscular/cardiac functions
in mouse models of age-associated muscle weakness (Gomes et al. 2013), Friedreich’s
ataxia cardiomyopathy (Martin et al. 2017), and transverse aortic construction-induced
heart failure (C. F. Lee et al. 2016). Therefore, it is intriguing to hypothesize that
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Figure 3-1. NAD+ biosynthesis pathways.
NAD+ is synthesized de novo from tryptophan (Trp) by the kynurenine pathway or from
forms of vitamin B3 such as nicotinic acid (NA), nicotinamide (NAM), nicotinamide
riboside (NR), and nicotinamide mononucleotide (NMN) through salvage pathways. QA,
quinolinic acid. NAMN, nicotinic acid mononucleotide. NaAD, deamido-NAD.
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supplementation of NR or NMN may improve the mitochondrial function of CL-deficient
cells by elevating NAD+ levels or the NAD+/NADH ratio.
In this study, I tested the working hypothesis that CL deficiency affects NAD+ levels
and/or redox and supplying NR or NMN improves mitochondrial function in CL-deficient
cells. Herein, I report that: 1) the yeast CL synthase mutant crd1Δ exhibits a decreased
NAD+/NADH ratio; 2) NMN supplementation elevates the respiratory capacity of the
mutant and improves cell growth on non-fermentable carbon sources; 3) NMN restores
the decreased NAD+ levels of TAZ-KO C2C12 myoblast cells, increasing the NAD+/NADH
ratio and mitochondrial membrane potential; 4) both NR and NMN rescue the decreased
exercise endurance of the Drosophila TAZ mutant (TAZ889). The findings in multiple model
organisms support the working hypothesis and suggest a therapeutic potential of NMN
and NR in the treatment of BTHS.
MATERIALS AND METHODS
Yeast Strains and Growth Media
The yeast strains used in this study are WT (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0)
and crd1Δ (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 crd1Δ::KanMX6) in the BY4741
genetic background. crd1Δ was obtained from the yeast knock-out deletion collection
(Invitrogen).
Synthetic complete (SC) medium contained amino acids including adenine (20.25
mg/L), arginine (20 mg/L), histidine (20 mg/ L), leucine (60 mg/ L), lysine (200 mg/L),
methionine (20 mg/L), threonine (300 mg/L), tryptophan (20 mg/L), uracil (20 mg/L); yeast
nitrogen base that contains ammonium sulfate (5 g/L), boric acid (0.5 mg/L), copper
sulfate (40 μg/L), iodide (0.1 mg/L), ferric chloride (0.2 mg/L), manganese sulfate (0.4
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g/L), sodium molybdate (0.2 g/L), zinc sulfate (0.4 mg/L), monopotassium phosphate (1
g/L), magnesium sulfate (0.5 g/L), sodium chloride (0.1 g/L), and calcium chloride (0.1
g/L); and vitamin mix that contains Biotin (2 μg/L), calcium pantothenate (0.4 mg/L), folic
acid (2 μg/L), inositol (2 mg/L), niacin (0.4 mg/L), p-Aminobenzoic Acid (0.2 mg/L),
pyridoxine hydrochloride (0.4 mg/L), riboflavin (0.2 mg/L), thiamine hydrochloride (0.4
mg/L). Niacin-free medium contained all the above-mentioned ingredients except niacin
as indicated in the figures. Galactose (2%), sodium pyruvate (2%), glycerol (2%), and
sodium lactate (2%) were added as carbon sources as indicated.
Mammalian Cell Lines and Growth Conditions
The TAZ-KO C2C12 myoblast strain was constructed by Lou et al. using the CRISPRCas9 system (Lou et al. 2018a). Growth medium consisted of DMEM (Gibco) containing
10% FBS (Hyclone), 2 mM glutamine (Gibco), penicillin (100 units/ml) and streptomycin
(100 μg/ml) (Invitrogen). Cells were grown at 37°C in a humidified incubator with 5% CO2.
Drosophila Strains and Growth Conditions
The Drosophila TAZ mutant (TAZ889) was constructed from the w1118 line using the
CRISPR-Cas9 system. The first 889 base pairs from the first exon of the TAZ gene were
deleted. The mutated site is tagged with a red fluorescent protein (RFP) for selection. The
genome editing, microinjection, validation, and stock establishment were completed by
Well Genetics (Taiwan, China). Flies were raised on a 10% sugar-yeast medium and were
housed at 25°C in a 12-hour light/dark incubator for their whole lives. All the Drosophila
work was performed by my kind collaborator Deena Damschroder from the Wessells
laboratory in the Department of Physiology, School of Medicine, Wayne State University
(Detroit, MI).
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Yeast Spotting Assay
Yeast cells were grown in SC-galactose medium to the stationary phase at 30°C,
washed with sterile water, and diluted to an A550 of 0.5. 5 μL aliquots of the series of 10fold dilutions were spotted onto the indicated plates and incubated at the indicated
temperatures.
Yeast Growth Curve
Yeast cells in the stationary phase were inoculated to fresh medium to the
concentration indicated at time zero and incubated with aeration at 230 rpm. A550 of each
culture was measured every few hours.
Measurement of NAD(H)
Yeast metabolites were extracted with a modified boiling ethanol method (Gonzalez
et al. 1997). Briefly, 200 μL of freshly harvested culture at the mid-logarithmic phase were
immediately dropped into a 15 mL capped tube containing 1.3 mL of boiling ethanol
buffered with 120 μL 1 M HEPES (pH 7.5) and incubated for 3 minutes (min). After cooling
down on ice for 3 min, the volume was reduced by evaporation using a speed vac
concentrator. The residue was resuspended in 100 μL double-distilled water and
centrifuged for 10 min at 5000 g at 4°C.
To extract metabolites from C2C12 cells, 7,500 cells in 100 μL medium were seeded
on a treated 96-well plate (CytoOne) and incubated overnight. After treatment with vehicle
(H2O) or 1 mM NMN for 5 hours, cells were washed twice with warm PBS and lysed with
0.2N NaOH containing 1% DTAB. Half of the lysate was treated with 0.4N HCl in a new
well. All lysates were heated at 60°C for 15 min. After cooling down at room temperature
for 10 min, samples were neutralized by HCl/Trizma or Trizma (Sigma).
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Levels of NAD+, NADH, and the NAD+/NADH ratio were analyzed with the
NAD/NADH-GloTM assay kit (Promega) following the manufacturer’s instructions. Briefly,
10 μL metabolites described above were loaded onto a 384-well low-volume white plate
(Corning) and mixed with 10 μL assay reagent mix. Relative light units (RLU) were read
on a plate reader (Molecular Devices, Spectra Max GEMINI XPS) after a 1-hour
incubation at room temperature in the dark. The linearity, sensitivity, and specificity of
NAD assays were determined using NAD+ and NADH (Sigma) standards. NAD+ and
NADH levels were normalized to protein levels.
Measurement of Ethanol
Cells were grown to the logarithmic phase at A550 of 0.5 to 1, collected by
centrifugation, and washed twice with sterile water. Following resuspension in fresh
medium, the samples were diluted with fresh medium to A550 of 0.5. After the indicated
hours of incubation at high temperature, 1 ml of culture was transferred quickly to a 1.7
ml centrifuge tube and centrifugated at maximum speed, 4°C, for 1 min. 400 μl of
supernatant were transferred to a new tube. To measure ethanol in the supernatant, a
colorimetric assay kit (Sigma) was used according to the manufacturer’s manual.
Measurement of Mitochondrial Membrane Potential (ΔΨm)
ΔΨm of C2C12 cells was measured using TMRM fluorescence staining. 7,500 cells
in 100 μL medium were seeded on a cell culture-treated 96-well plate. Cells were treated
with vehicle (H2O) or 1 mM NMN for five hours, followed by incubation with 50 nM TMRM
for 30 min at 30°C. After washing twice with prewarmed PBS, the fluorescence intensity
(FI) at Ex548/Em574 and the area covered [%] by cells (confluency) of each well were
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read on a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices). FI of each
well was normalized to the area covered by cells (confluency x 0.32 cm2) to indicate ΔΨm.
Measurement of Respiration
Yeast cells in the mid-logarithmic phase were diluted with fresh medium to an A550 of
0.5. The oxygen consumption rate (OCR) of each diluted sample was determined using
the polarographic method in a closed chamber equipped with a Clark electrode
(Oxytherm+ System, Hansatech) at 30°C as described (Lou et al. 2018b). 5 μM FCCP
was added to uncouple OXPHOS to measure the maximum OCR. 0.2 mM KCN was
added at the end to inhibit complex IV to correct for complex IV-independent oxygen
utilization. OCR was analyzed with Oxygraph plus software and was defined as
consumed O2 (nmol)/min/total protein (mg).
Measurement of Drosophila Endurance
Drosophila were collected within 48 hours of enclosing (age day 1). Flies were
transferred to vials containing food that are mixed with NR, NMN, or vehicle (H2O) at age
day 5 and once a day for the following five days. The endurance of the flies was measured
at age day 10. The Power Tower used for endurance exercise was set up as described
previously (Tinkerhess et al. 2012). In brief, the Power Tower stimulates flies to climb by
knocking them to the bottom of their container every 8 seconds. The endurance of the
flies is determined by the time to fatigue, when 80% of flies within a vial have stopped
climbing. These experiments were performed by Deena Damshroder in Dr. Wessells
laboratory, as mentioned above.
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Statistical Analysis
All statistical analyses were performed using two-tailed unpaired Student’s t test
unless specified (n.s., P >0.05; *, P≤ 0.05; **, p≤0.01; ***, p≤0.001; ****, p≤0.0001).
RESULTS
Yeast crd1Δ requires NAD precursors for optimal growth at high temperature.
The yeast CL synthase mutant crd1Δ has defects in ETC function (Cruciat et al.
2000; K. Pfeiffer et al. 2003; M. Zhang et al. 2002). Inhibition of the ETC may result in a
reduced NAD+/NADH ratio (Berthiaume et al. 2019). Therefore, I predicted that the
NAD+/NADH ratio is decreased in crd1Δ. As observed in Chapter 2 (Fig. 2-3), crd1Δ
exhibited decreased growth in SC-galactose medium at 38ºC (Fig. 3-2A). Under this
condition, crd1Δ at the mid-logarithmic phase showed a significant decrease in the
NAD+/NADH ratio when compared to that of WT (Fig.3-2B), as predicted. NAD+
precursors Trp and niacin are common components of synthetic complete (SC) medium.
Trp is a much less effective NAD+ precursor compared to niacin in humans (Horwitt et al.
1981) and is likely the least preferred precursor in yeast cells as well (Croft et al. 2020).
Therefore, blocking NAD+ salvage pathways is expected to exacerbate the temperature
sensitivity of crd1Δ that is associated with the reduced NAD+/NADH ratio (Fig.3-2B).
Indeed, crd1Δ grew more poorly on medium lacking niacin (Fig. 3-2C). Taken together,
the data suggest that crd1Δ has a reduced NAD+/NADH ratio and that NAD+ synthesized
from salvage pathways is required for the optimal growth of crd1Δ under stress.
NMN improves the mitochondrial function of crd1Δ.
Supplementation of NR or NMN has been shown to improve mitochondrial function
by increasing NAD+ levels and/or the NAD+/NADH ratio in mammalian cell lines and
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Figure 3-2. The NAD(H) redox balance is disrupted in crd1Δ.
(A) Precultures in the stationary phase were inoculated to a concentration of A550=0.05
in fresh SC-galactose medium and incubated with aeration. A550 was measured at
indicated times. Data shown are mean ± S.D. (n=3). (B) Cells grown in galactose
medium to the mid-logarithmic phase. 200 μL freshly harvested culture at the midlogarithmic phase were immediately lysed with buffered boiling ethanol. The
NAD+/NADH ratio was measured as described in Materials and Methods. Data shown
are mean ± S.D. (n=3). (C) WT and crd1Δ cells were grown in synthetic complete (SC)
medium containing 2% glucose to the stationary phase. 5 μL from 10-fold serial dilutions
of each culture (A550=0.5) were spotted on SC-galactose medium with or without niacin.
Plates were incubated at 38 ºC for 4 days.
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animal studies (Canto et al. 2012; Long et al. 2015; Sims et al. 2018). Herein I tested if
NMN improves the mitochondrial function of yeast crd1Δ. Decreased mitochondrial
function results in increased fermentation (Chapter 2). Therefore, I tested if ethanol
production by crd1Δ is decreased when NMN is supplied. As seen in Fig. 3-3, treatment
with 2 mM NMN for six hours decreased ethanol production in both WT and crd1Δ in
galactose medium at a high temperature, suggesting that OXPHOS was likely increased.
I further tested if NR or NMN improves the growth of crd1Δ in media containing only nonfermentable carbon sources. In pyruvate medium, 10 mM NR or NMN significantly
improved the growth of crd1Δ (Fig. 3-4A&B). A similar result was observed in medium
containing 2% sodium lactate and 2% glycerol (Fig. 3-4C), suggesting an improvement
in mitochondrial performance. Compared to crd1Δ in pyruvate medium, crd1Δ in glycerollactate medium grew to a much higher density in the ~40-hour logarithmic phase,
suggesting more robust cellular growth. To determine if improved growth resulted from
increased respiratory capability, I assayed the oxygen consumption rate (OCR) of cells
grown in glycerol-lactate medium (Fig. 3-5). It was surprising that unsupplemented crd1Δ
cells exhibited only insignificant decreases in basal and maximum OCR compared to WT,
suggesting that the difference in their growth during the mid-logarithmic phase (Fig. 34C) did not result from ETC defects in crd1Δ. In glycerol-lactate medium, NMN improved
the growth of both WT and crd1Δ (Fig. 3-4C) without increasing the basal OCR (Fig. 35A), suggesting that the increased growth probably does not result from increased ETC
activity. Nevertheless, I observed a 20.4% increase in the maximum OCR of crd1Δ when
treated with 2 mM NMN, consistent with an improvement in respiratory capacity (Fig. 35B). Taken together, the findings suggest that NMN improves OXPHOS activity of crd1Δ

Ethanol (nM)
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Figure 3-3. NMN decreases ethanol production by WT and crd1Δ during heat
stress.
WT and crd1Δ cells were grown in 4 ml SC-galactose medium to the mid-logarithmic
phase at 30°C. 4 ml fresh medium were added to each sample before transfer to at 39°C.
After 1.5 hours, cells were washed twice with sterile water, resuspended and diluted to
A550=0.45 with fresh medium, followed by 6 hours heat stress before samples were
collected and measured as described in Materials and Methods. Data shown are mean
± S.D. (n=4).
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Figure 3-4. NR or NMN supplementation rescues the growth defect of crd1Δ grown
in pyruvate and glycerol lactate media.
(A) WT and crd1Δ cells were grown to the stationary phase in SC-glucose medium. 5 μL
from 10-fold serial dilutions of each culture (A550=0.5) were spotted on SC-pyruvate
medium supplemented with 10 mM nicotinamide riboside (NR) or nicotinamide
mononucleotide (NMN). Plates were incubated at 38 ºC for 4 days. Pre-cultures in the
stationary phase were inoculated to fresh (B) pyruvate medium or (C) glycerol-lactate
medium to concentrations at A550=0.15. NMN or vehicle (water) was supplied as
treatment. A550 was determined at the indicated times during the incubation at 30°C. The
data represent the results of two independent experiments.

52

A
nmol O2 /min, mg total protein
OCR (mol/min, mg protein)

Basal OCR
60

WT

15%, p=0.133

crd1Δ
40

20

0

-

+

-

+

NMN (2 mM)

nmol O2 /min, mg total protein

B

Figure 3-5. NMN improves the respiration capacity of crd1Δ grown in lactateglycerol medium.
WT and crd1Δ cells were grown to the mid-logarithmic phase in SC-lactate glycerol
medium in the presence or absence of supplemented 2 mM NMN. 1 ml of each culture
that was diluted to A550=0.5 with fresh medium was used for measuring (A) basal and
(B) maximum oxygen consumption rates (OCRs) as described in Materials and Methods.
Data shown are mean ± S.D. (n=3).
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in galactose medium during heat stress and elevates the respiratory capacity in glycerollactate medium. NMN improves the growth of WT and crd1Δ in glycerol-lactate medium
without increasing the basal ETC activity as well.
NMN increases the NAD+ content and the NAD+/NADH ratio of TAZ-KO C2C12
myoblast cells and elevates their mitochondrial membrane potential (ΔΨm).
Our lab has constructed a mouse TAZ knockout (TAZ-KO) C2C12 myoblast strain
using the CRISPR-Cas9 system (Lou et al. 2018a). Similar to BTHS patients, the TAZKO cells exhibit decreased total CL levels, accumulated MLCL, elevated reactive oxygen
species (ROS), decreased ΔΨm, aberrant respiration, and elevated lactate production
(Lou et al. 2018a). TAZ deficiency results in reduced ETC stability and activity (Lou et al.
2018a; McKenzie et al. 2006). As the constitutive location for regenerating NAD+ from
NADH under aerobic conditions, ETC defects predict a decreased NAD+/NADH ratio.
Surprisingly, unsupplemented WT and TAZ-KO cells showed similar NAD+/NADH ratios
(Fig. 3-6A). However, TAZ-KO cells exhibited significantly decreased levels of NAD+. To
a lesser extent, the levels of NADH were decreased in the mutant (Fig. 3-6B). Therefore,
while the ratios did not differ greatly, the overall levels of NAD and NADH were decreased
in the mutant. Increased fermentation (Lou et al. 2018a), which regenerates NAD+ from
NADH, and the decreased total NAD(H) pool size (Fig. 3-6B) could contribute to the
decreased NADH levels in TAZ-KO. The decreased total NAD+ in TAZ-KO could result
from decreased biosynthesis and/or increased consumption (see Discussion).
NMN significantly increased the NAD/NADH ratio in TAZ-KO cells. The content of
NAD+ but not NADH was increased, suggesting that NMN increases the NAD+/NADH
ratio mainly by increasing the NAD+ content. The increases in NAD+ levels and the
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Figure 3-6. NMN increases the NAD+/NADH ratio in TAZ-KO C2C12 cells by
increasing levels of NAD.
5.2x10^4 WT or TAZ-KO C2C12 cells were seeded in a 24-well plate for overnight
incubation. After supplementation with 1 mM NMN for 4 hours, the cells were lysed for
the measurement of (A) NAD+/NADH ratio and (B) NAD(H) levels as described in
Materials and Methods. NAD(H) levels were normalized to protein levels. Data shown are
mean ± S.D. (n=6).
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Mitochondrial membrane potential

Figure 3-7. NMN increases the mitochondrial membrane potential of TAZ-KO cells.
WT and TAZ-KO cells grown in a 96-well plate were treated with 1 mM NMN for 5 hours
when the confluency reached ~50%. After staining with 50 nM TMRM for 30 min, the
cells were washed twice gently with pre-warmed PBS. The fluorescence intensity (FI) at
Ex548/Em574 was normalized to area covered by cells in each well. Data shown are
mean ± S.D. (n=18).
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NAD+/NADH ratio by NMN were not significant in WT cells, suggesting that the effect of
NMN is specific to TAZ-KO. NMN has been shown to increase ΔΨm and OXPHOS activity
in aged mice, which is featured by reduced NAD+ levels (Tarantini et al. 2019). In
agreement, Fig. 3-7 shows that NMN elevated the decreased ΔΨm of TAZ-KO by 43.45%,
suggesting an improvement in mitochondrial polarization and integrity.
Taken together, the findings suggest that NAD+ content declines in TAZ-KO
myoblast cells and that NMN supplementation increases the NAD+ content and,
consequently, the NAD+/NADH ratio, improving mitochondrial integrity and function.
NR and NMN improve the endurance of the Drosophila Taz889 mutant.
(This part of the work was performed by collaborator Deena Damschroder in the Wessells
laboratory in the Department of Physiology, School of Medicine, Wayne State University,
Detroit, MI)
The high content of mitochondria in specialized flight muscles makes Drosophila
advantageous for studying mitochondrial dysfunction (Sohal 1976; Xu et al. 2006b). It has
been shown that disruption of TAZ in flies (Taz-/-) results in reduced levels and
diversification of CL and decreased flying ability (Xu et al. 2006b). Consistent with the
findings of Xu et al., the Taz889 mutant in this study exhibited decreased exercise
endurance, which was determined by “time-to-fatigue” (Fig. 3-8). Supplementation of 1
mM NR (Fig. 3-8A) or 10 mM NMN (Fig. 3-8B) for five days in adulthood increased the
endurance of the Taz889 flies to almost WT levels, suggesting improved energy
metabolism and exercise expenditure of the mutant. NR or NMN did not significantly affect
the performance of WT, suggesting that the improvement in energy metabolism by the
NAD precursors is specific to the Taz889 mutant. The findings suggest that NMN and NR
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Figure 3-8. NMN and NR significantly increase the endurance of the Taz889 flies.
Food containing (A) 1 mM NR or (B) 10 mM NMN was supplied to WT and Taz889 flies
from their age day 5. The endurance of the flies at age day 10 was measured as
described in Materials and Methods. Data are representative of eight vials (20 flies per
vial) and at least two separate cohorts for each treatment were tested and analyzed with
log-rank test.
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improve the energy metabolism and energy expenditure of CL-deficient flies, likely by
improving mitochondrial function.
DISCUSSION
NAD+ content and NAD+/NADH ratio exert critical roles in cellular metabolism.
Although BTHS is a mitochondrial disease, very little is known about NAD+ metabolism in
this disorder. The current study demonstrates for the first time that CL deficiencies lead
to a reduced NAD+/NADH ratio or reduced NAD+ levels in yeast, mammalian cells, and
fruit flies. Supplementation of NMN improves mitochondrial function in all three models,
suggesting a therapeutic potential of the vitamin in treating BTHS.
As the site for oxidation of NADH in aerobic cellular respiration, the ETC is critical
in maintaining the intracellular NAD+/NADH ratio, alterations of which could greatly impact
cellular metabolism. Inhibiting OXPHOS by limiting oxygen or complex I/III inhibitors
decreases the NAD+/NADH ratio; conversely, increasing ETC activity with uncouplers
increases the ratio (Duchen et al. 2003; Y. Yang and Sauve 2016). It has been well
characterized that CL is required for optimal OXPHOS by directly binding with respiratory
complexes (Eble et al. 1990; Fry and Green 1981; Lange et al. 2001; Ozawa et al. 1982;
Robinson 1993) and promoting their associations (Acehan et al. 2011a; K. Pfeiffer et al.
2003; Ren et al. 2014; M. Zhang et al. 2002). CL deficiency in BTHS leads to decreased
ETC function (Barth et al. 1996; Dudek et al. 2013; Xu et al. 2005). In agreement with
these findings, I observed a decreased NAD+/NADH ratio in crd1Δ at high temperature a condition that has been shown to exacerbate mitochondrial dysfunction in this mutant
(Jiang et al. 2000) (Fig. 3-2). However, in TAZ-KO cells, the decrease in the NAD+/NADH
ratio cells is not statistically significant (Fig. 3-6A), likely as a result of decreases in the
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levels of both NAD+ and NADH (Fig. 3-6B). This finding differs from the observed
accumulation of NADH observed in BTHS lymphoblasts (Gonzalvez et al. 2013). One
possible explanation for this discrepancy is that the TAZ-KO C2C12 cells increase lactate
production by three fold when compared to controls (Lou et al. 2018a). Fermentation is
accompanied by the oxidation of NADH. It is noteworthy, though, that increased lactate
was observed in a differentiation medium (Lou et al. 2018a), which is likely more stressful
to mitochondria. The significant decrease in the NAD+ content of the TAZ-KO cells (Fig.
3-6B) is not explained by increased fermentation, but rather suggests decreased
biosynthesis and/or increased consumption. It is well documented that NAD+ content
declines with aging and in mitochondrial disorders (Camacho-Pereira et al. 2016;
Frederick et al. 2016; Massudi et al. 2012; Yaku et al. 2018), suggesting a common
association between mitochondrial defects and NAD+ deficiency. Although no previous
reports have identified a link between CL deficiency and decreased synthesis of NAD+,
observations in TAZ mutants have suggested an increased consumption of NAD by
sirtuins, PARPs, and NAD kinase (NADK). Sirtuins and PARPs consume NAD+ as a
substrate (Bai 2015; Blander and Guarente 2004) to improve mitochondrial function by
regulating mitochondrial biosynthesis (Prolla and Denu 2014). BTHS lymphoblasts exhibit
increased mitochondrial mass, likely to compensate for the loss of mitochondrial function
resulted from CL deficiency (Xu et al. 2005). These findings agree with the decreased
NAD+ levels in TAZ-KO cells. NADK also consumes NAD+ and NADH, generating NADP+
and NADPH. NADP+ is an important coenzyme in anabolism and antioxidative stress. In
humans, NADP+ produced by NADK appears to be reduced immediately to NADPH
(Agledal et al. 2010). NADPH is required for the redox regeneration of glutathione (GSH),
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which is one of the most important antioxidant molecules in cells. It is possible that TAZKO cells consume NAD(H) to generate NADP(H) in response to accumulated ROS that
results from CL deficiency (Q. He et al. 2014a). The yeast crd1Δ mutant exhibits
decreased growth on niacin-free medium (Fig. 3-2C), suggesting a deficiency of NAD+ in
crd1Δ that requires replenishment by the salvage pathway as well. These findings
strongly imply that deficient CL results in decreased NAD+, which has a profound impact
on cellular metabolism.
NMN and NR have been shown to improve mitochondrial performance by boosting
NAD+ levels and/or increasing the NAD+/NADH ratio (Gomes et al. 2013; Schondorf et al.
2018; Sims et al. 2018; Q. Yang et al. 2020). NMN improves the mitochondrial function
of yeast crd1Δ, as evidenced by decreased ethanol production in galactose medium (Fig.
3-3), increased growth on non-fermentable carbon sources (Fig. 3-4), and elevated
respiratory capacity (Fig. 3-5B). While decreased ethanol production suggests that
OXPHOS is increased (Fig. 3-3), it could in theory directly result from an elevated
NAD+/NADH ratio. In other words, NMN increases the NAD+/NADH ratio that is favorable
for the oxidase activity of ADHs but not their reductase activity. In addition to the improved
mitochondrial performance of crd1Δ, the findings in Fig. 3-4C and Fig. 3-5 also suggest
a growth advantage associated with NMN that is not dependent on the ETC activity in
glycerol-lactate medium. Specifically, crd1Δ exhibits a decreased growth rate in the midlogarithmic phase (Fig. 3-4C) when grown on non-fermentable carbon sources, but the
cells do not exhibit a significantly decreased basal OCR (Fig. 3-5), suggesting that
mechanisms other than ETC activity result in the difference in growth. Under this condition,
NMN does not improve the basal OCR of either WT or crd1Δ (Fig. 3-5A) but does improve
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the growth of both (Fig. 3-4C), suggesting a role of NMN in improving the use of lactate
and/or glycerol as carbon sources independently of ETC activity or CL. Nevertheless,
NMN elevates the respiratory capacity of crd1Δ (Fig. 3-5C), suggesting an improvement
in the ETC integrity. Furthermore, NMN increases the NAD+ content and NAD+/NADH
ratio of TAZ-KO cells without elevating NADH levels (Fig. 3-6), improving the
mitochondrial integrity and polarization (Fig. 3-7). Similar to a previous observation (Lou
et al. 2018a), TAZ-KO cells show a ~50% decrease in ΔΨm (Fig. 3-7). NMN increases the
ΔΨm of TAZ-KO cells by 43.45%, suggesting a restoration of ETC function, based on
which increased respiratory rate and capacity are expected. Drosophila has been an
excellent model for studying mitochondrial disorders due to its relatively short life cycle,
high content of mitochondria in flight muscles, and spontaneous flying behavior
(Sanchez-Martinez et al. 2006; Sohal 1976; Xu et al. 2006b). The exercise endurance of
Drosophila reflects their energy expenditure and metabolism. Consistent with the
previously observed decreased flying ability in the Taz-/- Drosophila (Xu et al. 2006b), the
Taz889 Drosophila exhibit decreased exercise endurance (Fig. 3-8). NR and NMN restore
the reduced exercise endurance to almost WT levels (Fig. 3-8), suggesting that promoting
NAD+ synthesis using the precursors improves energy metabolism in the CL-deficient
flies.
In summary, the current study characterizes aberrant NAD+ metabolism resulting
from CL deficiency. Importantly, it shows that increasing NAD+ levels or the NAD+/NADH
ratio by NMN or NR improves mitochondrial function in all three models, including yeast,
Drosophila, and mammalian cells. These findings suggest a therapeutic potential of NMN
and NR in treating BTHS and other CL-associated mitochondrial disorders. The specific
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mechanisms whereby NAD+ precursors improve the mitochondrial performance of CLdeficient cells are yet to be determined. One interesting direction is to determine if NAD+responsive proteins such as sirtuins and PARPs mediate mitochondrial biosynthesis and
stress tolerance (Canto et al. 2015; Srivastava 2016). It is also intriguing to study if other
metabolic pathways or enzymes that are defective in BTHS, including glycolysis, PDH,
and the TCA cycle, respond to NAD+ restoration. Studies on these directions could
provide valuable insights into energy metabolism caused by CL deficiency, especially into
the mechanisms of pathology in BTHS, which remain unknown to date.
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CHAPTER 4
ROLE OF CARDIOLIPIN IN MITOCHONDRIAL RESPONSE TO STRESS
INTRODUCTION
Mitochondria provide the majority of energy in the form of ATP to support complex
cellular functions. Aging and mitochondrial diseases such as Huntington’s disease,
Alzheimer’s disease, Parkinson’s disease, diabetes, and muscular dystrophy cause or
arise from mitochondrial dysfunction (Milakovic and Johnson 2005; Ruan et al. 2004;
Salminen et al. 2015; Sivitz and Yorek 2010; Turki et al. 2012). The Foundation for
Mitochondrial Medicine reported that 1 in 2,500 people are affected by mitochondrial
disease. One mechanism underlying mitochondrial disorders is oxidative stress, because
mitochondria are a major source of damaging reactive oxygen species (ROS).
ROS are generated from the electron transport chain (ETC), which is localized in
the inner mitochondrial membrane (IMM). During oxidative phosphorylation (OXPHOS),
complexes I, III, and IV of the ETC pump protons to the intermembrane space (IMS),
generating an electrical gradient potential (mitochondrial membrane potential, ΔΨm)
across the IMM, which is used by ATPase to produce ATP. ΔΨm reflects the bioenergetic
capacity of a cell; therefore, it is an important physiological parameter of mitochondria.
Electrons that leak from the ETC, especially from complexes I and III, are prematurely
accepted by oxygen, producing ROS, mainly superoxide (O2-) (St-Pierre et al. 2002). ROS
can target and oxidize fatty acids, lipids, proteins, and nucleotides, causing injuries such
as enzyme inactivation, lipid peroxidation, and genetic mutations. It has been well
accepted that the generation of ROS depends exponentially on ΔΨm (exceeding 140 mV)
(Korshunov et al. 1997; Skulachev 1996; Starkov and Fiskum 2003). However, in many
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cases, especially in mitochondrial disorders, reduced ΔΨm and increased ROS are both
observed (Lebiedzinska et al. 2010), suggesting an opposite correlation between the two
parameters.
The negative correlation between ΔΨm and ROS could result from the abnormal
activity of cytochrome c (cyt c), which is localized in the IMS. Cyt c is not integrated into
the IMM. Under normal conditions, it electrostatically interacts with the mitochondrial
membrane phospholipid cardiolipin (CL) and delivers electrons from complex III to
complex IV. In cells with mitochondrial dysfunction, cyt c and CL could bind tightly via
hydrophobic interaction as a result of decreased ATP levels (Sinibaldi et al. 2011).
Disruption of the cyt c structure converts it into a peroxidase that oxidizes CL (Tyurina et
al. 2006). Decreasing the role of cyt c as an electron carrier elevates electron leakage
and, therefore, increases ROS production and decreases ATP production. In addition to
alterations of cyt c activity, inhibition of the ETC, e.g., by inhibiting complex III, would
inhibit build-up of ΔΨm and increase the leakage of electrons at the same time, promoting
the generation of ROS. Nevertheless, the relationship between ΔΨm and ROS in
response to different mitochondrial challenges has not been well-studied.
The yeast Saccharomyces cerevisiae has been an excellent model to study
mitochondrial disorders due to its attributes of fast growth and amenability to
mitochondrial and genome editing. Importantly, the high fermenting capacity allows yeast
cells to survive mutations that inactivate OXPHOS or lead to the loss of mitochondrial
DNA (ρ0 petite) (Ephrussi and Slonimski 1955; Piskur 1994). To model mitochondrial
disorders associated with oxidative stress in S. cerevisiae, exogenous oxidants such as
hydroperoxide (H2O2) and tert-butyl hydroperoxide (tBHP) (Krasowska et al. 2000;
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Munhoz and Netto 2004), ETC inhibitors such as the complex III inhibitor antimycin A,
and mutations affecting mitochondrial function are often used. Although yeast has
contributed greatly to understanding mitochondrial biology, one limitation of using yeast
in the context of oxidative stress is that, unlike mammalian cells, mature CL in laboratorygrown yeast cells are not oxidizable (Lou et al. 2018b). In mammalian cells, mature CL
contains mainly oxidizable, polyunsaturated acyl chains, which are particularly
susceptible to ROS (Schlame et al. 2002). The peroxidation of CL has been associated
with several mitochondrial disorders, e.g., nonalcoholic fatty liver disease (NAFLD)
(Paradies et al. 2014). In addition, the activity of cyt c changes from a deliverer of
electrons in the ETC to CL peroxidase during conditions of low energy production (Tyurina
et al. 2006), suggesting that alterations in CL oxidation may affect how cells respond to
mitochondrial challenges. However, mature CL in yeast cells contains mainly palmitoleic
acid (C16:1) and oleic acid (C18:1), which are not highly oxidizable (Lou et al. 2018b). H.
brasiliensis Δ12-desaturase has been used to synthesize fatty acids with two double bonds,
resulting in the production of polyunsaturated, oxidizable CL (CLox) species that contain
C16:2 and C18:2 acyl chains (Lou et al. 2018b). Currently, few studies have reported
mitochondrial physiology in the presence of CLox. In addition, comprehensive analyses
of mitochondrial physiology in response to stress of different sources are lacking.
The current study attempts to determine how ΔΨm responds to stress induced by
oxidants, respiratory complex inhibitors, and mutations in the presence or absence of
oxidizable CL. An innovative method was developed to simulate mammalian ischemiareperfusion (I-R). Additionally, the effect of SS-31 (also known as elamipretide, MTP-131,
and Bendavia), which has been shown to rescue mitochondrial dysfunction in mammalian
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cells (Hao et al. 2015; Szeto and Birk 2014) was tested using intact yeast cells. Findings
in this study provide valuable insights into yeast mitochondrial physiology in response to
various sources of mitochondrial stress, adding value to yeast as an excellent model for
studying mitochondrial disorders.
MATERIALS AND METHODS
Yeast Strains, Plasmids, and Growth Media
The yeast S. cerevisiae strains used in this study are BY4741 (MATa his3Δ1
leu2Δ0

met15Δ0

ura3Δ0),

crd1Δ

(MATa

his3Δ1

leu2Δ0

met15Δ0

ura3Δ0

crd1Δ::KanMX6), sod2Δ (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 crd1Δ::KanMX6), and
cox12Δ (MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 crd1Δ::KanMX6) from the yeast knockout deletion collection (Invitrogen). Plasmids used are pYES2 (vector) and pYES2-Δ12desaturase (Lou et al. 2018).
Synthetic complete medium (SC) contained adenine (20.25 mg/L), arginine (20
mg/L), histidine (20 mg/L), leucine (60 mg/L), lysine (200 mg/L), methionine (20 mg/L),
threonine (300 mg/L), tryptophan (20 mg/L), uracil (20 mg/L), yeast nitrogen base without
amino acids (Difco), all the essential components besides inositol of Difco vitamin, 0.2%
ammonium sulfate, 75 μm inositol. Galactose (2%) or glycerol (2%) and ethanol (1%)
were added as carbon sources.

Solid medium was prepared by adding 2% agar.

Synthetic drop out medium contained all the ingredients mentioned above except the
amino acid as a selectable marker.
Growth Curve
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Yeast precultures grown to the stationary phase were inoculated to fresh medium to
the concentration indicated at time zero and incubated at the indicated temperatures with
shaking at 230 rpm. A550 of each culture was measured every few hours (hrs).
Measurement of Respiration
Oxygen consumption rate (OCR) of yeast cells was determined via the polarographic
method in a closed chamber equipped with a YSI Model 5300A Clark electrode at 30°C.
Cells were grown in SC-glycerol ethanol (SCGE) medium to an A550 of 0.5 to 0.8. After
dilution with fresh medium to an A550 of 0.5, 4 ml of each culture were loaded into the
chamber. State 3 respiration was determined in the presence of 6 μM FCCP. 0.2 mM
KCN was added at the end to inhibit cytochrome c activity for normalization of cytochrome
c-independent oxygen consumption. Oxygen consumption rates are defined as
consumed O2% per min.
Measurement of Mitochondrial Membrane Potential (ΔΨm)
Yeast cells at the mid-logarithmic phase were treated with 500 nM TMRM for 30
min at 30°C. After washing twice with prewarmed fresh medium by centrifugation, cells
were resuspended in 5 ml fresh medium. 500 µl resuspended cells were loaded into 1.2
ml polypropylene tubes (Fisher). The fluorescence intensity (FI) of TMRM (as determined
by PE-A) of 10,000 particles was measured with a BD LSR II flow cytometer at the Wayne
State University Microscopy, Imaging and Cytometry Resources Core. The FI of TMRM
was also determined in the presence of 6 µM FCCP. The median fluorescence intensities
(MFI) of both single cells and budding cells were analyzed with FlowJo. MFI (ΔΨm) = MFI
(FCCP-untreated) - MFI (FCCP-treated).
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The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by
NIH Center grant P30 CA22453 to the Karmanos Cancer Institute, Wayne State
University, and the Perinatology Research Branch of the Nation Institutes of Child Health
and Development. The measurement of ΔΨm was completed in collaboration with a
former member of our lab, Dr. Wenxi Yu.
Simulation of Ischemia-Reperfusion (I-R) in Yeast
To stress cells with an ischemia-like condition, mid-log phase cells grown in a 50
ml falcon tube were collected quickly by centrifugation and resuspended in prewarmed
1x PBS. Nitrogen was gently blown into the tubes to chase out oxygen. The lid of the tube
was quickly closed to maintain the oxygen-free environment. After shaking at 30°C for 15
min, PBS was replaced with prewarmed fresh medium and cells were recovered in a
shaking incubator for 15 min to simulate reperfusion before TMRM staining as described
above.
Statistical Analysis
All statistical analyses were performed using two-tailed unpaired Student’s t test
(n.s., P >0.05; *, P≤ 0.05; **, p≤0.01; ***, p≤0.001; ****, p≤0.0001).
RESULTS
The effect of mitochondrial stress induced chemically, genetically, and
physiologically on mitochondrial membrane potential (ΔΨm).
ΔΨm is an important physiological mitochondrial parameter that reflects the
capacity of a cell to generate ATP during OXPHOS. To obtain a comprehensive
understanding of how mitochondria react to diverse sources of mitochondrial stress, cells
were chemically treated with oxidants, including H2O2, tBHP, mito-AAPH, and
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peroxynitrite (HNO3-), and respiratory complex inhibitors that included the complex III
inhibitor antimycin A and the complex IV inhibitor sodium azide (NaN3). Genetically, the
superoxide dismutase 2 mutant sod2Δ and the complex IV subunit mutant cox12Δ were
used. To simulate I-R, a severe mitochondrial challenge to mammalian cells, yeast cells
were treated with nutritional and O2 starvation (ischemia, I) followed by recovery in fresh
medium with aeration (reperfusion, R).
As seen in Fig. 4-1, the oxidants 1 mM mito-AAPH and 3 mM H2O2 dissipated ΔΨm,
suggesting a decreased capacity of the cells to generate ATP. The finding that H2O2
results in a decreased ΔΨm was reproduced with 500 μM H2O2 (Fig. 4-2A). In agreement,
cells exposed to H2O2 exhibited decreased respiration in glycerol-ethanol medium (Fig.
4-2B). 1.2 mM tBHP and 100 nM peroxynitrite increased ΔΨm (Fig. 4-1), suggesting
hyperpolarization of the mitochondria. This is likely because, unlike other tested oxidants,
tBHP and peroxynitrite specifically inhibit NADH dehydrogenase and cyt c, respectively
(Nowak and Bakajsova-Takacsova 2018) (see Discussion). The complex inhibitors 1
μg/ml antimycin A and 1 mM sodium azide decreased ΔΨm (Fig. 4-1), suggesting that
inhibiting yeast complex III or complex IV results in decreased capacity of energy
production. In agreement, the complex IV subunit mutant cox12Δ exhibited decreased
ΔΨm as well. Cells lacking SOD2 did not exhibit altered ΔΨm, likely because ROS do not
significantly accumulate under this experimental condition. In other words, the activity of
Sod2 in eliminating ROS is not required. Consistent with what has observed in
mammalian models (Hüttemann et al. 2012; Sanderson et al. 2013), I-R induced ΔΨm
hyperpolarization in yeast cells as well (Fig. 4-1). To validate this finding, I-R was induced
in more replicates in media that contain galactose (Fig. 4-3A) and glycerol-ethanol (Fig.

70

Single cells
MFI

A

-SS-31

Budding cells
cellsMFI

+SS-31

W

T

PH
inA zide itrit
HP
c
A
B
a
y
n
t
A
xy
im
t
ito
o
r
m
an
pe
e

2Δ 12Δ
d
x
so
co

71

Single cells
MFI

B

-SS-31

Budding cells
cellsMFI

+SS-31

W

T

I -R

O2
H2

ito
m

P
AA

A
ci n
y
tim
an

H

az

ide

Figure 4-1. Effects of mitochondrial stress on ΔΨm.
WT cells at the logarithmic phase in SC-galactose medium were stressed for 50 minutes
(min) with (A) 1.2 mM tBHP (Luperox® TBH70X, tert-Butyl hydroperoxide), (B) 1 mM
mito-AAPH, 1 μg/ml antimycin A, 1 mM/ml sodium azide (NaN3), 100 nM peroxynitrite,
or 3 mM H2O2. After the cells were washed with fresh medium, ΔΨm was measured as
described in Materials and Methods. To determine the effect of SS-31, cells were treated
with 10 μM SS-31 for 40 min before stress, and once more at the 20-min time point
during stress. Data shown are mean (n=2).
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Figure 4-2. Effects of H2O2 on ΔΨm and respiration.
(A) Cells in the mid-logarithmic phase in SC-galactose medium were treated with 10 μM
SS-31 for 30 min before addition of 500 μM H2O2. ΔΨm was measured as described in
Materials and Methods. (B) Cells grown in SCGE medium were stressed with 500 μM
H2O2 for 30 min and/ or 10 μM SS-31 before measurement. OCR were measured as
described in Materials and Methods. Data shown are mean ± S.D. (A. n=3; B. n=4).
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Figure 4-3. Effects of I-R on ΔΨm in galactose and glycerol-ethanol media.
Cells were grown to the mid-logarithmic phase in (A) SC-galactose and (B) YPGE media,
respectively. I-R was simulated and ΔΨm was measured as described in Materials and
Methods. Cells were treated with 10 μM SS-31 for 30 min before I-R and during recovery
in fresh medium. Data shown are mean ± S.D. (A, n=5; B. n=4).
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4-3B), respectively. ΔΨm was increased significantly in both media, suggesting that
mitochondria respond to I-R similarly in both fermentable (galactose) and nonfermentable (glycerol and ethanol) carbon sources.
In summary, the findings show that: 1) Oxidants without a specific target and
inhibitors of complexes III or IV dissipate ΔΨm; 2) Oxidants that inhibit NADH
dehydrogenase or cyt c and I-R increase ΔΨm; 3) A lack of Sod2 does not affect ΔΨm
when ROS is not accumulated in healthy cells.
The effect of mitochondrial stress induced chemically, genetically, and
physiologically on ΔΨm in the presence of CLox.
Cyt c has been suggested to bind tightly with and oxidize CL when ATP production
is low (Kagan et al. 2005; Tyurina et al. 2006). As a result, CL-bound cyt c loses its ability
to deliver electrons in the ETC, increasing electron leakage and ROS production.
Therefore, the presence of CLox in cells may exacerbate any mitochondrial defect.
However, another study showed that the presence of polyunsaturated CL increases ΔΨm
and respiratory capacity (Lou et al. 2018b), suggesting a protective effect of CLox against
mitochondrial challenges. To determine how mitochondrial stress tested in Fig. 4-1 affects
mitochondrial physiology in the presence of CLox, the H. brasiliensis Δ12-desaturase was
expressed in WT cells. As shown by Lou et al., WT cells expressing the Δ12-desaturase
contain, predominantly CLox species including CL66:5, CL68:5, CL70:6 and CL72:7 (Lou
et al. 2018b).
As seen in Fig. 4-3, WT cells expressing the desaturase were more resistant to
oxidants H2O2 (Fig. 4-4A) and tBHP (Fig. 4-4B) when compared to controls expressing
empty vector, suggesting an increased antioxidative ability of the desaturase-expressing
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cells. It was surprising that mito-TEMPO, a mitochondrially targeted antioxidant, did not
rescue the oxidant-induced decrease in growth. However, there is no published evidence
that mito-TEMPO exerts antioxidant function in intact yeast cells. Nevertheless, to
determine if the protective effect is also observed in mitochondria, the desaturaseexpressing cells were challenged chemically and physiologically and ΔΨm was measured.
Similar to the results in Fig. 4-1, the oxidants mito-AAPH and H2O2 dissipated the
ΔΨm of cells expressing Δ12-desaturase and their controls. Expression of Δ12-desaturase
increased ΔΨm, suggesting that the presence of CLox species improves resistance of cells
to oxidative stress induced by mito-AAPH and H2O2. The other two oxidants, tBHP and
peroxynitrite, which were shown to increase ΔΨm in Fig. 4-1, also increased ΔΨm of cells
expressing Δ12-desaturase (Fig. 4-5). However, when compared to controls, expression
of Δ12-desaturase further increased ΔΨm. A higher level of hyperpolarization could be
damaging to the cells in the long term by inducing higher levels of ROS (Discussion).
Treatment with inhibitors of complexes III and IV, antimycin A and sodium azide, which
decreased ΔΨm in the absence of CLox, led to a decreased ΔΨm in cells expressing Δ12desaturase as well (Fig. 4-5). However, when compared to controls, the expression of
Δ12-desaturase resulted in elevated ΔΨm when treated with antimycin A, but not sodium
azide. Considering the extremely low levels of ΔΨm in response to azide, the
concentration used appears to be toxic. I-R also increased ΔΨm of cells expressing Δ12desaturase, and the expression of Δ12-desaturase further increased ΔΨm, suggesting a
more damaging ROS burst later during reperfusion.
In summary, the findings suggest that the presence of CLox species in yeast cells
elevates ΔΨm in conditions that induce hypo- and hyper-polarization. Therefore, CLox
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Figure 4-4. Expression of Δ12-desaturase improves the growth of WT cells under
oxidative stress induced by H2O2 and tBHP.
Growth was determined as described in Materials and Methods. Data shown represent
mean values (n=2). (A) 1 mM H2O2, or (B) 800 μM tBHP were added 1 hr before each
time A550 was taken, 1.6 mM tBHP was added 1 hr before A550 at the 9-hr point was
taken. 10 μM SS-31 and 50 μM mito-TEMPO were added along with H2O2 and tBHP.
Data shown are mean (n=2). EV, empty vector.
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Figure 4-5. Expression of Δ12-desaturase elevates ΔΨm.
WT cells expressing EV or Δ12-desaturase were grown to the mid-logarithmic phase in
SC-galactose medium. ΔΨm was measured as described in Materials and Methods after
treatment with (A) H2O2 3 mM, mito-AAPH 1 mM, 1 μg/ml antimycin A, (B) 1 μg/ml
antimycin A, or (C) 1 mM sodium azide for 50 min. To determine the effect of SS-31, cells
were treated with 10 μM SS-31 for 40 min before stress, and once more at the 20-min
time point during stress. Data shown are mean ± S.D. Data shown represent the mean
(A&B, n=2) or mean ± S.D. (C, n=4).
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species may exert a protective role against mitochondrial challenges that lower ΔΨm.
However, the presence of CLox may further stress cells with a more severe burst of ROS
production by building up a higher ΔΨm of cells with hyperpolarized mitochondria.
SS-31 did not protect intact yeast cells from oxidative stress.
SS-31 is a positively charged cell-permeable tetrapeptide (D-Arg-2', 6'dimethyltyrosine-Lys-Phe-NH2). It has been shown to reduce mitochondrial ROS
production, lower oxidative damage, and improve ATP production (Hao et al. 2015; Szeto
and Birk 2014). These effects account for protection against conditions such as skeletal
muscle disorders (Min et al. 2011), diabetic retinopathy (Alam et al. 2015), ischemic acute
kidney injury (AKI) (Tabara et al. 2014), and I-R injury (Birk et al. 2013; Brown et al. 2014;
Kloner et al. 2012) in animal models. Herein, the effects of SS-31 on yeast cells under
various oxidative stress were tested (Fig. 4-1 to Fig.4-5). However, no rescue of
mitochondrial defects was observed, suggesting that SS-31 does not protect intact yeast
cells against the mitochondrial challenges applied in this study or that it was not taken up
by the cells.
DISCUSSION
This study describes extensive analyses of mitochondrial physiology in response
to mitochondrial stress from different sources. For the first time, ΔΨm of yeast cells under
various mitochondrial challenges was measured and compared in the presence or
absence of CLox species. Herein, I report that inhibiting complexes III or IV chemically or
genetically results in decreased ΔΨm. However, I-R and inhibition of NADH
dehydrogenase or cyt c increase ΔΨm. The presence of CLox increases ΔΨm and protects
cells against oxidative stress. However, the CLox-induced increase in ΔΨm potentially
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damages cells with hyperpolarized mitochondria in the long term. The mitochondrial
protective role of SS-31 was not observed in yeast in this study. These findings provide
comprehensive understandings on yeast mitochondrial physiology under stress.
ΔΨm is an important physiological parameter of mitochondria that reflects the
bioenergetic capacity of a cell. Both high and low ΔΨm indicate abnormalities of OXPHOS
activity and are associated with damaging ROS. Decreased ΔΨm is often associated with
mitochondrial disorders and aging, suggesting decreased bioenergetic capacity. Both
exogenous oxidants and inhibition of ETC complexes have been shown to induce
depolarization of mitochondria. This study shows that exogenous oxidants H2O2 and mitoAAPH (Fig. 4-1B), dissipate ΔΨm. In the presence of ferrous ions, H2O2 generates
extremely active hydroxyl radicals that could oxidize lipids, proteins, and DNA
indiscriminately (Dizdaroglu and Jaruga 2012). AAPH has been shown to induce
overproduction of extracellular H2O2 (Barygina et al. 2019). Therefore, both H2O2 and
mito-AAPH may decrease ΔΨm by oxidizing and inhibiting the ETC. In agreement,
inhibition of complexes III and IV with inhibitors or mutations (Fig. 4-1) also reduces ΔΨm.
ΔΨm hyperpolarization is deleterious to cells because it leads to increased ROS
(Korshunov et al. 1997; Skulachev 1996; Starkov and Fiskum 2003). Conditions that
have been shown to result in ΔΨm hyperpolarization include I-R, inhibition of complex I or
V, and closure of mitochondrial permeability transition pores (mPTPs) (Forkink et al. 2014;
Hüttemann et al. 2012; Nowak and Bakajsova-Takacsova 2018; Sanderson et al. 2013;
Suski et al. 2012; Wojtczak et al. 1999). In this study, I report that simulation of I-R
increases ΔΨm in yeast cells as well. A model of brain I-R injury proposed by Sanderson
et al. described that the lack of oxygen during ischemia causes changes in the
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phosphorylation pattern of ETC complexes, resulting in build-up of electrons in IMS by
complexes I and III (Sanderson et al. 2013; Sanderson et al. 2018). However, posttranslational modification of the ETC has not been characterized in yeast cells. This study
also shows hyperpolarization induced by two oxidants, tBHP and peroxynitrite (Fig. 4-1).
Unlike H2O2 and mito-AAPH, which do not have specific targets, tBHP has been shown
to inhibit complex I specifically in rabbit renal proximal tubular cells (Nowak and
Bakajsova-Takacsova 2018). However, unlike mammalian complex I, yeast has NADH
dehydrogenases on both the OMM (Nde1,2) and IMM (Ndi1). Whether tBHP inhibits the
yeast NADH dehydrogenases has yet to be determined. A previous study has shown that
exogenous peroxynitrite dissipates ΔΨm (Brito et al. 2008), which is opposite to what was
shown in this study (Fig. 4-1). A possible explanation for the discrepancy is that the
peroxynitrite used in this study is at a significantly lower concentration (100 nM vs. 500
μM). Exogenous peroxynitrite at low concentrations may transiently increase ΔΨm as a
result of cyt c nitration and build-up of electrons by the activities of complex I and III. In
summary, this study characterized three conditions that result in yeast mitochondrial
hyperpolarization, including I-R and exogenous tBHP and peroxynitrite. However, the
mechanisms have yet to be determined
Studies in mammalian cells have shown that polyunsaturated CL is very
susceptible to ROS (Lyamzaev et al. 2019). The oxidation of CL results in accumulated
ROS (Sinibaldi et al. 2011; Tyurina et al. 2006) and has been associated with several
pathologies (Lyamzaev et al. 2019). However, Lou et al. suggested a protective effect of
polyunsaturated CL against ROS by showing increased respiration and ΔΨm in H.
brasiliensis Δ12-desaturase-expressing cells in the presence of H2O2 (Lou et al. 2018b).
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In agreement, this study shows that the expression of Δ12-desaturase improves the
growth of cells under oxidative challenge by H2O2 or tBHP (Fig. 4-4). It is likely because
oxidizable CL species protect proteins, DNA, and other lipids from oxidative damage by
becoming oxidized and being remodeled to non-oxidized species (Lou et al. 2018b).
Under conditions that depolarize mitochondria, including treatment with H2O2, mito-AAPH,
and antimycin A (Fig. 4-5A), an increase in ΔΨm could be protective, as it indicates a
higher capability of energy production. However, it may not be favorable for cells with
hyperpolarized mitochondria to further increase ΔΨm (Fig. 4-5B), which could lead to the
production of more ROS. Whether oxidizable CL species protect cells against
hyperpolarization remains unknown. Nevertheless, the findings suggest that oxidizable
CL increases ΔΨm in response to various mitochondrial challenges that cause both hypoand hyper-polarization indiscriminately.
SS-31 has been shown to scavenge spontaneous mitochondrial H2O2 emission
(Zhao et al. 2004) and prevent H2O2-induced mitochondrial depolarization and apoptosis
in mammalian models (M. Chen et al. 2011; M. Chen et al. 2017). It selectively targets
mitochondria and interacts with CL (Birk et al. 2013) and function potentially by modifying
the CL-cyt c hydrophobic interaction to recover the electron carrier function of cyt c (Birk
et al. 2014). The protective effect of SS-31 has been shown in various models of
mitochondrial disorders, including skeletal muscle disorders (Min et al. 2011), diabetic
retinopathy (Alam et al. 2015), ischemic acute kidney injury (AKI) (Tabara et al. 2014),
and I-R injury (Birk et al. 2013; Brown et al. 2014; Kloner et al. 2012). However, in the
current study, SS-31 did not exert a protective effect on intact yeast cells against
mitochondrial challenges, including H2O2 and H2O2-generating mito-AAPH, or in the

87
presence or absence of oxidizable CL. It is possible that SS-31 is not readily taken up by
yeast cells. Limited by the availability of labeled SS-31 (Birk et al. 2013; Zhao et al. 2005),
the cellular localization of SS-31 could not be determined in this study. However, yeast
cells are able to take up large cell-penetrating peptides. For example, the yeast S.
cerevisiae takes up pVEC, which contains 18 amino acid residues (Holm et al. 2005).
Considering that SS-31 contains only four amino acid residues and is highly permeable
in mammalian cells, it is unlikely that SS-31 does not enter yeast cells.
In summary, this study reports systematic analyses of ΔΨm in response to various
mitochondrial challenges and shows that inhibition of complexes III or IV decreases, and
I-R and inhibition of NADH dehydrogenase or cyt c increase ΔΨm. The presence of CLox
species protects cells from oxidative stress. However, CLox species may further
hyperpolarize mitochondria with a high ΔΨm, which is potentially damaging by inducing
ROS. CL oxidation has been shown to be closely related to CL remodeling, disruption of
which results in the severe human disease, Barth syndrome (Lou et al. 2018b).
Understanding the role of CLox species in mitochondrial physiology in response to various
mitochondrial challenges is important for understanding the mechanism of the disease.
The comprehensive analysis of ΔΨm under stress also adds value to yeast as an excellent
tool for modeling mitochondrial disorders.
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CHAPTER 5
SYNTHETIC GENETIC ARRAY (SGA) INDICATES NEW FUNCTIONS OF CLD1
INTRODUCTION
Cardiolipin (CL) is the signature phospholipid of mitochondria. It is predominantly
localized in the inner mitochondrial membrane (IMM), where it is generated exclusively
(Hostetler et al. 1972; Joshi et al. 2009). Unlike other phospholipids, CL contains two
phosphate head groups and four acyl chains and also carries two negative charges
(Lecocq and Ballou 1964; Pangborn 1947). CL is critical for the formation of cristae and
required for the optimal function of mitochondria (Ikon and Ryan 2017; Xu et al. 2005).
The CL synthesized de novo is remodeled by a process in which a CL phospholipase and
the transacylase tafazzin replace one acyl chain with a more unsaturated species through
deacylation and reacylation, respectively (Schlame 2013). Mutations in the human
tafazzin gene (TAZ) cause a life-threatening disorder, Barth syndrome (BTHS) (Barth et
al. 1983).
The budding yeast Saccharomyces cerevisiae has been widely used as a model for
studying CL for its highly conserved CL synthesis and remodeling pathways and relative
ease of genetic analysis and large-scale screens. The yeast tafazzin mutant taz1Δ is the
first published genetic model of BTHS (Gu et al. 2004; L. Ma et al. 2004). Similar to BTHS
patients, taz1Δ exhibits mitochondrial dysfunction, decreased levels of total and
unsaturated CL, and increased MLCL levels (Gu et al. 2004). Expression of the human
tafazzin gene TAZ in the yeast mutant rescued its defects (L. Ma et al. 2004). CLD1 is
the only CL-specific phospholipase that has been identified in yeast (Beranek et al. 2009).
Lack of CLD1 interrupts CL remodeling but does not affect the CL level (Baile et al. 2014;
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Beranek et al. 2009). Intriguingly, deletion of CLD1 from the taz1Δ mutant rescues its
defective respiratory growth, indicating that remodeled and un-remodeled CL are not
functionally distinguishable with respect to bioenergetics in yeast (Baile et al. 2014; Ye et
al. 2014). However, it is not known if Cld1-mediated CL remodeling affects other cellular
functions. The wide disparities in clinical phenotypes among BTHS patients suggest the
existence of physiological modifiers (Barth et al. 1983; Barth et al. 1996). The exploration
of the function of the first step of the CL remodeling process may shed light on the future
identification of BTHS physiological modifiers.
In this study, I took advantage of the ease of large-scale genetic screening in yeast
to gain insight into the biological processes that are functionally associated with Cld1. I
performed a Synthetic Genetic Array (SGA) with a specially constructed cld1Δ mutant
and analyzed the significant genome ontology (GO) terms that are generated from the
genes that exhibited genetic interactions with CLD1. It was revealed that Cld1 or its
metabolic products - MLCL and remodeled CL - may be functionally associated with
vacuole-related biological processes and protein urmylation / tRNA wobble uridine
modification. This is the first report indicating that the first step of CL remodeling is
functionally important for other biological processes, implicating new functions of Cld1.
MATERIALS AND METHODS
Yeast Strains, Growth Media, and Growth Condition
Synthetic complete media (SD) contained adenine (20.25 mg/l), arginine (20 mg/l),
histidine (20 mg/l), leucine (60 mg/l), lysine (200 mg/l), methionine (20 mg/l), threonine
(300 mg/l), tryptophan (20 mg/l), and uracil (20 mg/l), yeast nitrogen base without amino
acids (Difco, Detroit, MI), and glucose (2%). The synthetic drop-out media contained all
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of the above-mentioned ingredients except the amino acid as a selectable marker.
Sporulation medium contained potassium acetate (1%), glucose (0.5%), and the essential
amino acids. Complex media (YPD) contained yeast extract (1%), peptone (2%), and
glucose (2%). The solid media were prepared by adding 2% agar.
To construct the query strain, a MATa cld1Δ::URA3 mutant in the BY4741 genetic
background was mated with a MATα can1Δ::STE2pr-LEU2, ACP1-GFP (GFP::HIS5)
strain in the related BY4743 genetic background (Tavassoli et al. 2009) that was kindly
provided by Dr. Christopher Loewen from the University of British Columbia. A MATα
cld1Δ::URA3, can1Δ::STE2pr-LEU2 mutant was selected by tetrad scoring on YPD, Ura-,
Leu-, and His- plates. The genotypes were confirmed by PCR. The mating-type was
confirmed by mating the mutant with a MATa strain containing the complementary
nutritional makers and confirmation of growth of the diploid on amino acid-free medium.
Synthetic Genetic Array
The MATα cld1Δ::URA3, can1Δ::STE2pr-LEU2 mutant was crossed to an array of
nonessential gene mutants in the MATa (BY4741) background. All of the nonessential
genes were knocked out and linked to the dominant selectable marker KanMX4. Diploids
were selected on Ura-, G418+ synthetic medium. After sporulation was induced, haploid
spore progenies were transferred to Leu-, G418+, allowing for germination. Following two
rounds of selection on Leu-, G418+ medium, haploids were transferred to either Leu-, Ura-,
G418+ plates for growth of double mutants, or Leu-, 5-FOA, G418+ plates for growth of
single mutants carrying the selectable marker KanMX4. Two replicates of each treatment
were incubated at 30°C or 39°C. After three days, the growth of each double mutant was
compared to the growth of the corresponding single mutant. The construction of the
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strains used in this study and the genetic screen were completed in collaboration with a
former member of our lab, Dr. Cunqi Ye.
Data Analysis
GlueGO, a Cytoscape plug-in that integrates Gene Ontology (GO) terms and Kyoto
encyclopedia of genes and genomes (KEGG)/BioCarta pathways, was used to generate
GO/pathway annotation networks from lists of genes (Bindea et al. 2009). Biological
processes, cellular components, and molecular function terms that are significantly
relevant (pathway p value<0.05) to the query gene were organized into tables and
networks.
RESULTS
Genome-wide synthetic genetic array (SGA) screen with cld1Δ
To identify potential new functions of Cld1, I performed a genome-wide genetic
analysis using the SGA methodology, screening for genes that genetically interact with
CLD1 at either 30ºC or 39ºC.

In the SGA, the query strain (MATα cld1Δ::URA3,

can1Δ::STE2pr-LEU2, met15Δ0) was crossed to a deletion collection containing mutants
of about 4,800 non-essential genes in the MATa background (lys2Δ0). The selection of
diploids on Met-, Lys- drop out medium was followed by the induction of sporulation. The
STE2pr-LEU2 reporter expresses only in MATa cells, allowing for the selection of MATa
haploids on Leu- medium. Haploids were then transferred to either Leu-, Ura-, G418+
plates for the growth of double mutants, or Leu-, 5-FOA, G418+ plates for the growth of
single mutants carrying selectable marker KanMX4. 5-FOA is lethal to cells expressing
the URA3 reporter, therefore, only haploids without the cld1Δ::URA3 construct could
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survive. Synthetic genetic interactions were identified by comparing the growth of the
double mutants with the single mutant parent strains.
According to van Leeuwen et al., growth of cells reflects their fitness. The expected fitness
of a double mutant is equal to the relative fitness of one mutant multiplied by the relative
fitness of the other, when the fitness of a wild type (WT) control is scored 1 (Fig. 5-1A).
Based on the relative fitness of a double mutant, two categories of genetic interactions
may be determined (Fig. 5-1A): negative interaction, in which the double mutant exhibits
a fitness lower than the expected fitness; and positive interaction, where the double
mutant fitness is greater than expected but less than or equal to the sicker single mutant
(masking), or greater than the sicker single mutant (suppression) (Baryshnikova et al.
2010; Costanzo et al. 2010; Dixon et al. 2009; van Leeuwen et al. 2017). Both negative
interactions and suppressions may indicate functional relatedness (van Leeuwen et al.
2016).
Under the experimental conditions in this study, cld1Δ grew as well as WT did.
Therefore, the fitness of cld1Δ was scored 1. The expected fitness of a double mutant is
the same as that of corresponding single mutants (Fig. 5-1B). Accordingly, only negative
and suppression (but not masking) interactions could be determined. The genes in each
of the categories were grouped based on cellular component, biological process, and
molecular function. The significant genome ontology (GO) terms (pathway p value<0.05)
are listed in Tables 5-1 to 5-3 and the networks of the terms are shown in Fig. 5-2.
Cld1 functions revealed by suppression interactions at 30ºC
As shown in Table 5-1, most of the significant GO terms generated from the
suppression interactions at 30ºC are vacuole protein sorting (VPS) genes, including
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A

Positive

Suppression

B

Suppression

Figure 5-1. Genetic interactions (van Leeuwen et al. 2017)
(A). If the relative fitness of mutant xxxΔ and yyyΔ are 0.6 and 0.7, the expected fitness
of the double mutant xxxΔyyyΔ is 0.6 x 0.7=0.42. If the fitness score of xxxΔyyyΔ is
lower than 0.42, it indicates a negative interaction between the two mutants. In a
masking interaction, the fitness of xxxΔyyyΔ is higher than 0.42 but lower than 0.6. In a
suppression interaction, the fitness of a xxxΔyyyΔ is higher than 0.6. Both masking and
repression interactions are positive interactions. (B). In this study, cld1Δ grew as well
as WT did. Therefore, the expected fitness of the double mutant cld1ΔxxxΔ is the fitness
of xxxΔ. We can identify negative and suppression interactions in this context.

94
Table 5-1. Positive interaction with cld1Δ at 30ºC
%
Associated
Associated Genes Found
Genes
Found

GO Term
Cellular Component

75.00
5.49
4.59

[VPS51, VPS52, VPS53]
[VPS25, VPS30, VPS51, VPS52,
VPS53]
[VPS25, VPS30, VPS51, VPS52,
VPS53]

GARP complex
endosome membrane
endosomal part
Biological Process

50.00

[VPS51, VPS52, VPS53]

cellular sphingolipid homeostasis

16.00

[LOA1, VPS51, VPS52, VPS53]

lipid homeostasis

[VPS30, VPS51, VPS52, VPS53,
YPT6]
[VPS30, VPS51, VPS52, VPS53,
YPT6]
[VPS25, VPS30, VPS51, VPS52,
VPS53, YPT6]

retrograde transport, endosome
to Golgi

13.51
9.09
5.36
4.35

[ADA2, FKH2, UME1]

cytosolic transport
endosomal transport
regulation of chromatin
organization
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C

Figure 5-2. Significant gene ontology (GO) analysis.
Significant (p≤0.05) biological processes, cellular components, and molecular functions
were identified using Clue-GO as described in Materials and Methods. GO terms
generated by genes that exhibited positive interactions at 30ºC (A), positive interactions
at 39ºC (B), and negative interactions at 39ºC (C) were mapped.
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Figure 5-3. Vacuole and protein sorting.
Vacuoles (yeast equivalent of mammalian lysosomes) are critical for protein sorting,
which is carried out by anterograde transport, the secretory pathway, endocytosis, and
retrograde transport. Transport is mediated by different complexes, including the AP-3
adaptor complex, homotypic fusion and vacuole protein sorting (HOPS) complex,
Golgi-associated retrograde protein (GARP) complex, and endosomal sorting complex
required for transport (ESCRT). ALP, alkaline phosphatase; CPY, carboxypeptidase Y;
API, aminopeptidase I; Cvt, cytoplasm to vacuole; MVB, multivesicular body.
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VPS25, VPS30, VPS51, VPS52, and VPS53. The most significant term is the cellular
component “GARP complex” (Fig. 5-3), with 75% of the associated genes showed
suppression interactions with CLD1. GARP is the Golgi-associated retrograde protein
(GARP) complex, which is required for the recycling of proteins from endosomes to the
trans-Golgi network (TGN) and for cytoplasm-to-vacuole targeting (Cvt) vesicle
completion (Reggiori et al. 2003). GARP-associated biological process terms significantly
represented include “cellular sphingolipid homeostasis”, “lipid homeostasis”, “retrograde
transport, endosome to Golgi”, “cytosolic transport”, and “endosomal transport”. Among
the terms, “cellular sphingolipid homeostasis” is the most significant. It has been shown
that GARP deficiency results in the accumulation of sphingolipid synthesis intermediates
(Frohlich et al. 2015). Deletion of CLD1 from the associated mutants exhibited rescue of
growth defects, suggesting that Cld1 has an inhibitory role in GARP-related vacuolar
functions, including protein sorting and sphingolipid homeostasis. A hypothesized
mechanism is proposed in the Discussion.
Cld1 functions revealed by suppression interactions at 39ºC
Heat stress is a common strategy that is used to enable observations of
phenotypes that may not be observed when cells are grown at the optimal temperature.
Indeed, the number of significant GO terms and associated genes generated from
suppression interactions increased greatly at 39ºC as shown in Table 5-2.
The most significant biological process term identified under this condition is “protein
urmylation”. The associated genes that genetically interact with CLD1 are NCS2, NCS6,
and ELP2 (Fig. 5-4). Protein urmylation refers to the attachment of a ubiquitin-like protein
Urm1 to another protein, such as the peroxiredoxin Ahp1, which protects cells against
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Table 5-2. Positive interaction with cld1Δ at 39ºC
%
Associated
Associated Genes Found
Genes
Found

75.00

[APL6, APM3, APS3]

5.24

[APL6, APM3, APS3, MIC19, PEP8, POR1,
TOM7, VAM7, VMA3, VMA6, VMA7, VPS20,
VPS35, VPS41]

GO Term
Cellular
Component
AP-3 adaptor
complex
membrane protein
complex
Biological Process

42.86

[ELP2, NCS2, NCS6]

13.64

[NHA1, RAV2, TRK1, VMA3, VMA6, VMA7]

12.77

[NHA1, RAV2, TRK1, VMA3, VMA6, VMA7]

10.00

[APL6, APM3, APS3, ARL1, BRO1, IRS4,
RAS2, VAM7, VMA3, VPS27, VPS41]

10.00

[APL6, APM3, APS3, ARL1, BRO1, IRS4,
RAS2, VAM7, VMA3, VPS27, VPS41]

9.65

[APL6, APM3, APS3, ARL1, BRO1, IRS4,
RAS2, VAM7, VMA3, VPS27, VPS41]

8.28
4.89

4.85

4.79

4.65

[APL6, APM3, APS3, ARL1, BRO1, IRS4,
RAS2, VAM7, VMA3, VMA6, VPS20, VPS27,
VPS41, VPS53]
[APL6, APM3, APS3, ARL1, BLM10, BRO1,
COX19, IRS4, POR1, RAS2, RTG3, SKY1,
TOM7, VAM7, VMA3, VPS27, VPS41]
[APL6, APM3, APS3, ARL1, BLM10, BRO1,
BST1, COX19, GET2, IRS4, PEP8, POR1,
RAS2, RTG3, SKY1, TOM7, VAM7, VMA3,
VPS27, VPS35, VPS41]
[APL6, APM3, APS3, ARL1, BLM10, BRO1,
COX19, IRS4, POR1, RAS2, RTG3, SKY1,
TOM7, VAM7, VMA3, VPS27, VPS41]
[APL6, APM3, APS3, ARL1, BLM10, BRO1,
COX19, IRS4, PEP8, PMT1, POR1, RAS2,
RTG3, SKY1, TOM7, VAM7, VMA3, VPS27,
VPS35, VPS41]

protein urmylation
cellular monovalent
inorganic cation
homeostasis
monovalent
inorganic cation
homeostasis
protein targeting to
the vacuole
establishment of
protein localization
the to vacuole
protein
localizationthe to
vacuole
vacuolar transport
protein targeting
protein localization
to organelle
establishment of
protein localization
to organelle
intracellular protein
transport
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4.65

4.33

4.10

4.08

[APL6, APM3, APS3, ARL1, BLM10, BRO1,
BST1, COX19, GET2, IRS4, KSP1, LRP1,
PEP8, PMT1, POR1, RAS2, REF2, RTG3,
SEM1, SKY1, SPT4, SSD1, TOM7, VAM7,
VMA3, VPS27, VPS35, VPS41]
[APL6, APM3, APS3, ARL1, BLM10, BRO1,
BST1, COX19, GET2, IRS4, KSP1, PEP8,
PMT1, POR1, RAS2, REF2, RTG3, SEM1,
SKY1, TOM7, VAM7, VMA3, VPS27, VPS35,
VPS41]
[APL6, APM3, APS3, ARL1, BLM10, BRO1,
BST1, COX19, ELP2, IRS4, NCE101, PEP8,
PMT1, POR1, RAS2, RAV2, RTG3, SKY1,
TOM7, VAM7, VMA3, VPS20, VPS27, VPS35,
VPS41, VPS53]
[APL6, APM3, APS3, ARL1, BLM10, BRO1,
BST1, COX19, ELP2, GET2, IRS4, NCE101,
PEP8, PMT1, POR1, RAS2, RAV2, RTG3,
SKY1, TOM7, VAM7, VMA3, VPS20, VPS27,
VPS35, VPS41, VPS53]

cellular
macromolecule
localization

cellular protein
localization

protein transport

establishment of
protein localization
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Figure 5-4. tRNA wobble uridine modification.
(A) The majority of yeast cytoplasmic tRNA species with a uridine at position 34 (U34) are
modified at this position, which enables one anticodon to decode multiple codons and is
referred to as wobble modification. (B) The 5-methoxycarbonylmethyl-2-thiouridine
(mcm5s2U) modification of U34 on tRNAGluUUC, tRNAGlnUUG, and tRNALysUUU are
carried out by three pathways (B. Huang et al. 2008; Leidel et al. 2009; Tigano et al.
2015). Genes encoding Elp2, Ncs2, and Ncs6 exhibited suppression interactions with
CLD1 at 39ºC.
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oxidative damage (Lian et al. 2012). Interestingly, the urmlyation pathway and elongator
pathway (ELP) also function in the wobble uridine modification of cytoplasmic tRNAs
tRNAGluUUC, tRNAGlnUUG, and tRNALysUUU, which are important for the growth of cells
during heat stress (B. Huang et al. 2008; Leidel et al. 2009). Thiolation of the cytoplasmic
tRNALysUUU is also required for mitochondrial biogenesis at elevated temperatures
(Tigano et al. 2015). The suppression interactions between cld1Δ and the deletants of the
protein urmylation / cytoplasmic tRNA wobble modification genes at 39ºC suggest that
lacking Cld1 benefits oxidative resistance or improves mitochondrial biogenesis at a high
temperature (see Discussion).
“Cellular monovalent inorganic cation homeostasis” is the second most significant
biological process identified at 39ºC. The related suppressor genes are NHA1, RAV2,
TRK1, VMA3, VMA6, and VMA7. Vma3, Vma6, and Vma7 are subunits of the vacuolar
membrane H+-ATPase (V-ATPase). Rav2 is a subunit of the RAVE complex, which
mediates the glucose-induced reassembly of the V-ATPase (Seol et al. 2001; Smardon
et al. 2002; Smardon et al. 2014). V-ATPase is an ATP-driven proton pump that is
responsible for acidification of the vacuole and secretory organelles and generation of
proton gradient that drives the accumulation of Na+ and K+ in the vacuole (Cyert and
Philpott 2013; Kane 2006; Parra et al. 2014). Nha1 and Trk1 are the plasma membrane
Na+/H+ antiporter and K+ transporter, respectively (Madrid et al. 1998; Yenush et al. 2002).
The rescue effect of deletion of CLD1 from these mutants suggests that Cld1 negatively
regulates cellular inorganic ion homeostasis, likely the levels and the ratio of sodium and
potassium. At a high temperature, Cld1 interrupts the maintaining of electrical membrane
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potential or intracellular pH, possibly by altering the vacuolar CL content that affects VATPase activity (see Discussion).
Three of the four genes related to the cellular component term “AP-3 adaptor
complex” exhibited suppression interactions with CLD1. The AP-3 adaptor complex is a
heterotetrameric AP-type membrane coat adapter complex that functions in the trafficking
of alkaline phosphatase from the Golgi to the vacuole (Cowles et al. 1997; Stepp et al.
1997). The null mutant of any of the three suppressor genes, APL6, APM3, or APS3
exhibits defective vacuolar protein transport (Cowles et al. 1997). Deletion of CLD1 from
these mutants improved their fitness, suggesting that Cld1 negatively regulates vacuolar
protein transport.
Other terms significantly represented among the identified suppressor genes of
CLD1 include “protein localization to vacuole”, “vacuolar transport”, and “protein targeting”.
However, most of the terms contain more than 100 associated genes, indicating the high
generality of these pathways. In addition, fewer than 10% of the genes in each category
were identified to have suppression interactions with CLD1. Therefore, these terms are
less indicative of specific functions.
Taken together, the findings suggest that Cld1 may have a negative impact on
protein urmylation pathway-associated oxidative protection, mitochondrial biogenesis,
maintenance of electrical membrane potential, and vacuolar protein sorting at 39ºC.
Cld1 functions revealed by negative interactions at 39ºC
While 16 negative interactions were observed at 30ºC, only four interactions were
moderate to severe and the 16 associated genes did not identify any significant GO terms.
At 39ºC, only the molecular function term “N-methyltransferase activity” was identified
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(Table 5-3). The four genes identified are DOT1, GRR1, HPM1, and RKM3. Dot1 is a
nucleosomal histone methylase that is required for telomeric silencing and meiotic
checkpoint control (San-Segundo and Roeder 2000; Singer et al. 1998). Grr1 is a
component of the SCF ubiquitin-ligase complex that functions in carbon catabolite
repression (Flick and Johnston 1991; Vallier et al. 1994). It localizes to the nucleus,
cytosol, and the bud neck contractile ring (Blondel et al. 2000; Blondel et al. 2005). Hpm1
functions in the methylation of several proteins including the large ribosomal subunit
protein Rpl3p, which plays an important role in ribosome biogenesis and translation
elongation (Al-Hadid et al. 2016). Rkm3 catalyzes the methylation of the large ribosomal
subunit protein Rpl42 (Webb et al. 2008). Hpm1 and Rkm3 are localized to both the
nucleus and cytosol (Al-Hadid et al. 2014). Interestingly, both catalyze the methylation of
ribosomal subunits. The negative interactions identified at 39ºC suggest that Cld1 may
contribute to the N-methyltransferase activity at a high temperature through an unknown
mechanism. However, the importance of this interaction must be weighed against the
relatively small number of genes identified in this category.
DISCUSSION
In this study, I identified genes and biological processes that may be functionally
associated with Cld1 through a large-scale genetic screen identifying genetic interactions
with cld1Δ. The findings suggest that Cld1 may play a role in functions not previously
associated with this CL phospholipase, including vacuolar protein sorting, sphingolipid
homeostasis, monovalent inorganic cation homeostasis, protein urmylation / tRNA
wobble uridine modification, and N-methyltransferase activity, providing intriguing future
directions for studying CL remodeling and mechanisms of BTHS.
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Table 5-3. Negative interaction with cld1Δ at 39ºC
% Associated
Genes Found

Associated Genes Found

GO Term
Molecular Function

9.76

[DOT1, GRR1, HPM1, RKM3]

N-methyltransferase
activity
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Cld1 and vacuolar function
The vacuole is important for cellular pH- and ion- homeostasis, bulk degradation
of proteins, and storage of ions and nutrients (Thumm 2000). Previous studies in our lab
have shown that CL is required for vacuolar functions (S. Chen et al. 2008; Shen et al.
2017). Cells lacking CL exhibit enlarged vacuolar morphology, reduced V-ATPase activity,
and loss of vacuolar acidification at high temperatures (S. Chen et al. 2008). However,
the CL remodeling process has not been previously associated with vacuolar functions.
In this study, I report that mutants in 75% of the genes associated with the “GARP
complex” and the “AP-3 complex” exhibited repression interactions with CLD1 at 30ºC
and 39ºC, respectively. The two complexes are critical in maintaining vacuolar
morphology and vacuolar protein sorting (Reggiori et al. 2003; Stepp et al. 1997). In
addition, loss of the GARP complex function interrupts cellular sphingolipid homeostasis,
including the accumulation of sphingolipid intermediates and alterations in sterol
distribution (Frohlich et al. 2015). Therefore, it is not surprising that the biological process
terms “cellular sphingolipid homeostasis”, “lipid homeostasis”, and “retrograde transport,
endosome to Golgi” were identified at 30ºC and terms such as “protein targeting to
vacuole” and “vacuolar transport” were identified at 39ºC.
At 39ºC, the biological process “cellular monovalent inorganic cation homeostasis”
was also identified as a significant term. Four V-ATPase related genes (VMA3, VMA6,
VMA7, and RAV2) and two plasma membrane transporter genes (TRK1 and NHA1)
exhibited suppression interactions with CLD1. V-ATPase is an ATP-driven proton pump
that is responsible for the acidification of the vacuole and secretory organelles and
generates a proton gradient that drives the accumulation of Na+ and K+ in the vacuole
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(Cyert and Philpott 2013; Kane 2006; Parra et al. 2014). Trk1 is a plasma membrane K+
transporter (Yenush et al. 2002). By importing K+, it is essential in maintaining the high
intracellular ratio of K+/Na+ that is required for the activation of key metabolic processes
(Page and Di Cera 2006). Nha1 is a plasma membrane proton antiporter that functions in
both Na+ detoxification and K+ efflux, which are important in maintaining the membrane
potential (Madrid et al. 1998; Zahradka and Sychrova 2012). The suppression interactions
between CLD1 and the genes discussed above suggest that Cld1 exerts a negative
impact on the cellular K+/Na+ balance that is contributed by the V-ATPase activity.
What is the potential impact of Cld1 on vacuolar function? Given that Cld1 is
exclusively localized in mitochondria and peripherally associated with the inner leaflet of
the inner mitochondrial membrane (IMM) (Baile et al. 2013; Beranek et al. 2009), its role
in vacuolar function is likely conducted by its metabolic products. As shown in Fig. 5-5, in
the CL remodeling process, Cld1 deacylates CL, generating MLCL and free fatty acid
(FFA) (Beranek et al. 2009). Taz1 then transfers an acyl chain from phosphatidylcholine
(PC) or phosphatidylethanolamine (PE) to MLCL, generating byproducts lyso-PC (LPC)
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Figure 5-5. CL remodeling and proposed model that links Cld1 to vacuolar
function.
In the CL remodeling process, Cld1 deacylates CL, generating MLCL and free fatty
acid (FFA) (Beranek et al. 2009). Taz1 transfers an acyl chain from phosphatidylcholine
(PC) or phosphatidylethanolamine (PE) to MLCL, generating lyso-PC (LPC) and lysoPE (LPE) (Gu et al. 2004; Testet et al. 2005; Tyurina et al. 2017). Recycling of LPC by
yeast cells require the activity of phospholipase B 1/3 (Plb1/3) (M. Zhang et al. 2009),
which has been shown to be required for vacuolar functions potentially by altering the
phospholipid content of the vacuole membrane (Michaillat and Mayer 2013). I
hypothesize that deletion of Cld1 reduces the production of PLC, which competitively
inhibits the activity of Plb 1/3. Therefore, the Plb1/3 could optimize vacuolar lipid
content for its optimal vacuolar protein sorting and V-ATPase activities.
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and lyso-PE (LPE) (Gu et al. 2004; Testet et al. 2005; Tyurina et al. 2017). It has been
shown that the lack of Cld1 in yeast cells leads to a more saturated CL profile (Ye et al.
2014). Considering that CL represents ~1.6% of the phospholipid composition of yeast
vacuoles (Zinser et al. 1991), rescue of the growth defects of the vacuole-associated
genes by deletion of Cld1 may result from the more saturated CL content of the vacuole.
It is also reasonable to speculate that blocking deacylation inhibits the activity of Taz1,
reducing the production of byproducts LPC and LPE. Recycling of LPC by yeast cells
requires the activities of phospholipase B 1/3 (Plb1/3) (M. Zhang et al. 2009), mutations
in which lead to vacuole membrane fragmentation, potentially by altering the phospholipid
content of the vacuole membrane (Michaillat and Mayer 2013). Deletion of Cld1 may
reduce the production of LPC, which competitively inhibits the activity of Plb1/3 in
optimizing the lipid content of the vacuole membrane. As a result, vacuolar protein sorting
and V-ATPase activities are enhanced.
Cld1 is functionally associated with protein urmylation / tRNA wobble uridine
modification during heat stress
At 39ºC, I identified suppression interactions that suggest that CLD1 functions in
protein urmylation. The associated genes include NCS2, NCS6, and ELP2. Protein
urmylation is a ubiquitin-like process, in which the modifier Urm1 is conjugated to a
substrate protein (Furukawa et al. 2000). Known substrates include the peroxiredoxin
Ahp1, which protects cells against oxidative damage by reducing hydroperoxides (Lian et
al. 2012). Another role of the urmylation pathway is the modification of the uridine at
position 34 (U34) of cytoplasmic tRNAs to 5-methoxycarbonylmethyl-2-thiouridine
(mcm5s2U), specifically tRNAGluUUC, tRNAGlnUUG, and tRNALysUUU (B. Huang et al.
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2008; Leidel et al. 2009). Lacking the wobble uridine thiolation process reduces the total
protein levels and is tolerated at the expense of defective growth (Klassen et al. 2015).
Therefore, deletion of Cld1 may rescue the growth defects of the deletants of the
urmylation genes by activating unknown pathways that are responsible for translation
efficiency during heat stress.
Interestingly, at an elevated temperature, mitochondrial integrity also requires
Urm-Ncs-Elp-dependent thiolation of the cytoplasmic tRNALysUUU, which was suggested
to function in the translation of cytosolic proteins for mitochondrial gene expression and
function (Tigano et al. 2015). Yeast mitochondria have a relatively simple decoding
system that allows the decoding of all codons with a small set of mitochondrial encoded
tRNAs, which are wobble-modified by mitochondrial machinery (Bonitz et al. 1980). It was
shown that due to hypomodification of mitochondrial tRNALysUUU during heat stress,
import of cytosolic tRNALysCUU to mitochondria is indispensable for the growth of cells
under this condition (Kamenski et al. 2007; Schneider 2011). It is reasonable to speculate
that Cld1 inhibits pathways that are important for mitochondrial biogenesis and function
during heat stress, such as the import of cytosolic tRNALysCUU to mitochondria.
Removing the inhibition of mitochondrial biogenesis by deletion of Cld1 could result in
improvement in cell growth, as shown in Fig. 5-6.
Impact and limitations
This work identifies very interesting and novel functions of Cld1 for the first time
and suggests intriguing future directions for studies in CL remodeling and BTHS. The
yeast vacuole is a mammalian lysosome parallel. CL has been previously found to
associate mitochondria with vacuolar functions (S. Chen et al. 2008; Shen et al. 2017),
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Figure 5-6. Working model that links Cld1 to cytoplasmic tRNA wobble uridine
modification.
At position 34 of cytoplasmic tRNAGluUUC, tRNAGlnUUG, and tRNALysUUU, uridine is
modified to to 5-methoxycarbonylmethyl-2-thiouridine (mcm5s2U) (B. Huang et al. 2008;
Leidel et al. 2009). This process is required for optimal protein translation and therefore
optimal cell growth (Klassen et al. 2015). At an elevated temperature, thiolation of the
cytoplasmic tRNALysUUU and import of the tRNALysCUU are required for mitochondrial
biogenesis and function (Kamenski et al. 2007; Tigano et al. 2015). The reliance on the
import of tRNALysCUU was shown to be associated with the hypo- wobble modification
of the mitochondrial tRNALysUUU (Kamenski et al. 2007; Schneider 2011). Therefore, if
Cld1 inhibits the processes indicated, deletion of Cld1 from cells lacking tRNA wobble
modification genes may rescue their growth defects by improving mitochondrial
biogenesis and function.
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the importance of which is underscored by abnormal lysosomes found in several
cardiovascular disease conditions (e.g. Pompe disease and Danon disease) (Chi et al.
2019; Leslie et al. 1993) and the fact that BTHS is featured by cardiomyopathy. My data
suggest that blocking the deacylation of CL to MLCL improves the health of mutants with
vacuolar defects, which may lead to new insights into studying lysosomal function and
treating cardiomyopathy in BTHS. The repression interactions between CLD1 and genes
function in protein urmylation and tRNA wobble modification suggest an inhibitory role of
Cld1 in mitochondrial biogenesis and function under a stressful condition. BTHS patient
lymphoblasts have a significantly higher content of mitochondria, which is considered to
compensate for deficiency in oxidative phosphorylation (Xu et al. 2005). In light of these
findings, inhibition of CL deacylation is a potential way to improve mitochondrial function
by elevating mitochondrial biogenesis, which may have implications in treating BTHS.
While the implications of the current study are potentially exciting, scrupulous
validation of the genetic interactions is essential. To this end, the putative interactions
described in this study should be confirmed with tetrad analysis (Tong et al. 2004) as,
similar to other high-throughput screens, the SGA screen is subject to false-positive and
negative results. Nevertheless, the identification of multiple genes within progresses such
as the “GARP-complex”, the “AP-3 adapter complex”, and “protein urmylation” lends to
confidence in the genetic interactions among these processes. Mining the presented
findings is expected to facilitate a better understanding of the role of CL remodeling and
BTHS.
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CHAPTER 6
FUTURE DIRECTIONS
This thesis describes important findings revealing the novel roles of CL and CL
remodeling in cellular metabolism, mitochondrial physiology, and other biological
processes. Chapters 2 and 3 report that abnormal NAD+ metabolism results in CLassociated metabolic alterations and that supplementation of NAD+ precursors improves
mitochondrial function and corrects some metabolic abnormalities. A comprehensive
analysis of mitochondrial physiology in response to different mitochondrial challenges in
the presence or absence of oxidizable is described and discussed in Chapter 4. In
addition, a large-scale genetic study of the yeast CL remodeling gene Cld1 in Chapter 5
revealed biological processes that are functionally associated with the first step of CL
remodeling.
In this chapter, I present a model derived mainly from the studies in Chapters 2
and 3, which describes how the CL-associated ETC defect results in abnormal NAD+
metabolism. Increasing the NAD+/NADH ratio by NAD precursors normalizes metabolic
abnormalities and promotes bioenergetics. Both the novel findings of metabolic
perturbation in CL-deficient cells and the large-scale genetic study of Cld1 have identified
very intriguing directions for future study. By exploring these directions and pushing the
limit of our knowledge, future students may reveal exciting new roles of CL and CL
remodeling at critical junctures of cellular metabolism and essential biological processes.
1. Model: altered NAD+ metabolism results in metabolic changes in CL-deficient
cells.
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The metabolic studies summarized in Chapters 2 and 3 suggest a unified model
with which to understand the complex inter-relationship between NAD+ and metabolic
abnormalities in CL-deficient cells (Figure 6.1). Unlike mammalian cells, yeast cells
preferably ferment glucose. However, in galactose, yeast relies on oxidative
phosphorylation (OXPHOS) for energy production because the net yield of ATP from
galactose metabolism by the Leloir pathway and glycolysis is zero. During respiration, the
electron transport chain (ETC) is the constitutive location for the oxidation of NADH,
regenerating NAD+, which supports the continuation of glycolysis, oxidation of pyruvate
to acetyl-CoA, and the TCA cycle. CL is long known to be required for optimal function of
the ETC by directly binding to respiratory complexes and optimizing their association (Ren
et al. 2014). CL-associated ETC defects result in a decreased NAD+/NADH ratio. The
decreased ratio favors fermentation, during which pyruvate is reduced to lactate (most
eukaryotes) or ethanol (yeast) (Chapter 2); however, it inhibits the activities of pyruvate
dehydrogenase (PDH) as well as dehydrogenases in the TCA cycle. Supplementation of
NAD+ precursors such as nicotinamide mononucleotide (NMN) increases the
NAD+/NADH ratio by increasing the content of NAD+. As a result, fermentation is
decreased, TCA cycle metabolism is increased, and ETC function is improved (Chapter
3).
The novelty of this model is that it ties together many metabolic alterations that
have been reported in CL-deficient cells, including decreased synthesis of acetyl-CoA in
crd1Δ (Raja et al. 2017), reduced pyruvate dehydrogenase (PDH) activity and decreased
[U-13C] glucose flux to the TCA cycle in TAZ-KO C2C12 cells (Li et al. 2019), and lactic
acidosis in Barth syndrome (BTHS) patients.
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Figure 6-1. Model: altered NAD+ metabolism results in metabolic changes in CLdeficient cells.
The electron transport chain (ETC) regenerates NAD+ from NADH, maintaining a
relatively high NAD+/NADH ratio under normal conditions. The regenerated NAD+
supports the continuation of glycolysis, oxidation of pyruvate to acetyl-CoA, and TCA
cycle. CL deficiency results in ETC defects, which lead to a decreased NAD+/NADH ratio.
The decreased ratio favors fermentation, during which pyruvate is reduced to lactate
(most eukaryotes) or ethanol (yeast) (Chapter 2), and inhibits activities of
dehydrogenases in the TCA cycle and pyruvate dehydrogenase (PDH).
Supplementation of NAD+ precursors such as nicotinamide mononucleotide (NMN)
increases the NAD+/NADH ratio by increasing the content of NAD+. As a result,
fermentation is decreased, and TCA cycle metabolism is increased (Chapter 3).
OXPHOS, oxidative phosphorylation. NMN, nicotinamide mononucleotide.
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2. Does NMN increase the flux of glucose to the TCA cycle?
In Chapter 3, I demonstrated that supplementation of NMN increases the
NAD+/NADH ratio and improves mitochondrial function in several CL-deficient models.
As discussed previously, the NAD+/NADH ratio regulates the activities of enzymes. PDK,
which mediates the inhibitory phosphorylation of PDH, can be activated by a decreased
NAD+/NADH ratio (Park et al. 2018). Titov et al. showed that increasing the mitochondrial
NAD+/NADH ratio by expressing a bacterial NADH oxidase (mitoLbNOX) in HeLa cells
decreases the phosphorylation of the catalytic subunit of the PDH complex - PDH-E1α
(Titov et al. 2016). I speculate that altered NAD+/NADH may contribute to the observed
~50% decrease in PDH activity in TAZ-KO C2C12 cells (Li et al. 2019). PDH-E1α
phosphorylation was not studied in these cells. It will be interesting to investigate if NMN
supplementation affects the levels of PDH-E1α phosphorylation and elevates PDH
activity by increasing the NAD+/NADH ratio.
If PDH activity is increased by NMN, an increased flux from glucose to the TCA
cycle is expected. Furthermore, the NAD+/NADH ratio is also expected to affect the
activities of TCA cycle enzymes that require NAD+ as a coenzyme, including isocitrate
dehydrogenase, α-ketoglutarate dehydrogenase, and malate dehydrogenase. The TCA
cycle is the metabolic hub of eukaryotic cells. Previous studies have shown that yeast
crd1Δ exhibits decreased synthesis of acetyl-CoA (Raja et al. 2017) and reduced
activities of the TCA cycle enzymes aconitase and succinate dehydrogenase (Patil et al.
2013). Li et al. reported decreased flux of [U-13C] glucose to the TCA cycle in TAZ-KO
C2C12 cells (Li et al. 2019), which may be associated with the broad metabolic
dysregulation that has been characterized in BTHS patients. It would be valuable to study
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if NMN supplementation increases the [U-13C] glucose flux to the TCA cycle, especially
to the intermediates produced by the dehydrogenases mentioned above.
3. Can replenishing the TCA cycle intermediates with amino acids rescue the
growth defect of CL-deficient cells?
Due to the importance of TCA cycle function, a surplus pool of TCA cycle
intermediates is maintained during periods of high or low energy consumption (Owen et
al. 2002). As mentioned above, the TAZ-KO C2C12 cells exhibit decreased TCA cycle
metabolism (Li et al. 2019). Replenishing the TCA cycle intermediates may be beneficial
to CL-deficient cells.
In addition to the oxidation of acetyl-CoA, TCA cycle intermediates can be
replenished by anaplerotic pathways such as carboxylation of pyruvate to oxaloacetate,
β-oxidation, the carnitine shuttle (Fig. 6-2), the glyoxylate cycle (in yeast), and catabolism
of certain amino acids (Fig. 6-3). In cells with dysfunctional mitochondria, there is a
concomitant increase in the expression of genes involved in various anaplerotic pathways
(Epstein et al. 2001).
As shown by Raja et al., the yeast crd1Δ mutant exhibits synthetic lethality with mutants
in the TCA cycle, retrograde (RTG) pathway, glyoxylate cycle, and pyruvate carboxylase.
In addition, the mutant exhibits glutamate auxotrophy and decreased levels of glutamate
(Raja et al. 2019b). Oleate supplementation rescues growth defects, suggesting that TCA
cycle deficiency in CL mutants necessitates activation of anaplerotic pathways to
replenish acetyl-CoA and TCA cycle intermediates (Raja et al. 2019b). It has been
suggested that consuming a specific “cocktail” of amino acids may be beneficial for the
treatment of metabolic dysfunction in BTHS patients (Antunes et al. 2019; Reynolds 2015).
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Figure 6-2. Metabolic pathways for replenishing TCA cycle intermediates.
The TCA cycle carries out the oxidation of acetyl-CoA for the production of reducing
equivalents. Additionally, TCA cycle intermediates are precursors for other biosynthetic
pathways (not shown). Anaplerotic pathways such as the glyoxylate cycle (in yeast)
and pyruvate carboxylase (in yeast and mammals) can generate oxaloacetate,
succinate, and citrate, which can directly replenish TCA cycle intermediates diminished
by utilization in biosynthetic pathways. Peroxisomal and cytosolic acetyl-CoA derived
from β-oxidation and acetate may be imported into the mitochondria by the carnitine
shuttle. (For simplicity, the glyoxylate cycle is depicted inside of the peroxisome, but
several enzymes are cytosolic).
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Figure 6-3. Metabolic fates of amino acids in the TCA cycle.
Amino acids can supply TCA cycle intermediates by catabolism as shown (red) or
through pyruvate (green). The 4- and 5-carbon intermediates must be coupled with
exit processes such as gluconeogenesis and production of fatty acids (blue). These
processes are termed cataplerosis.

121
However, at present, there is a dearth of systematic studies aimed at identifying
replenishing amino acids and metabolites and the mechanism(s) by which they may
confer their beneficial effects.
In a preliminary study, I supplied the TCA cycle intermediate α-ketoglutarate and
pyruvate (Fig. 6-4) and individual amino acids, including arginine, methionine, and
isoleucine (Fig. 6-5), to WT, crd1Δ, and taz1Δ cells grown on synthetic minimal medium
containing 2% glycerol plus 1% ethanol as carbon sources. The results showed that
supplying these intermediates and amino acids partially rescues the growth defects of
crd1Δ and taz1Δ. Although vitamin B6 (pyridoxine) is not an amino acid, it is an important
coenzyme that functions in the transsulfuration pathway, which is critical in methionine
metabolism. Supplementation of vitamin B6 improves the growth of both crd1Δ and taz1Δ
at 30ºC, and that of taz1Δ at 37ºC (Fig. 6-6).
One concern about this preliminary study relates to the nutritional auxotrophies of cells in
the BY4741 background. Histidine, leucine, methionine, and uracil must be provided in
minimal medium for the cells to survive. It is possible that the high amino acid content
supplied in the medium masks the rescue effect of some other amino acids. Dr. Cunqi Ye
(Life Sciences Institute, Zhejiang University, China) provided a wild type CEN.PK strain
that does not carry any nutritional markers. crd1Δ and taz1Δ mutants should be
constructed in this background to determine the nutritional profile that rescues the growth
defects of yeast caused by CL-deficiency.
I anticipate that successful completion of the proposed experiments will contribute
to the development of dietary interventions for BTHS patients that include simple
supplements that are safe, readily available, and have the potential to improve
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Figure 6-4. Supplementation of α-ketoglutarate and pyruvate partially rescues the
decreased growth of crd1Δ on SCGE plates.
α-ketoglutarate (0.01% ) or pyruvate (0.05% ) was added to SC minimal amino acid
medium containing glycerol (2%) plus ethanol (1%) as carbon sources. Cells were grown
to the stationary phase at 30°C, then serially diluted and spotted on plates with the
indicated supplements and incubated at 30°C for 8 days.
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Figure 6-5. Supplementation of amino acids partially rescues the temperaturesensitive phenotype of crd1Δ.
Individual amino acids, including arginine (1%), methionine (2%), or isoleucine (2%),
were added to SC minimal amino acid medium containing glycerol (2%) plus ethanol
(1%) as carbon sources. Cells were grown to the stationary phase at 30°C, then serially
diluted and spotted on plates with the indicated supplements and incubated at 37°C for
11 days.
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Figure 6-6. Supplementation of vitamin B6 partially rescues the growth defect of
crd1Δ and taz1Δ.
Vitamin B6 at the indicated concentrations was added to SC minimal amino acid
medium containing glycerol (2%) plus ethanol (1%) as carbon sources. Cells were
grown to the stationary phase at 30°C, then serially diluted and spotted on plates with
the indicated supplements and incubated at 30°C for 5 days or at 37°C for 11 days.
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their quality of life.
4. What is the role of Cld1 in sphingolipid metabolism?
The synthetic genetic array (SGA) screen to identify potential cellular and
molecular functions of Cld1 described in Chapter 5 indicates that sphingolipid metabolism
may be functionally related to Cld1 (Table 5-1). Several genes that function in sphingolipid
metabolism (Fig. 6-7A) were deleted from cld1Δ to validate this finding. As seen in Fig.
6-7B, cld1Δ exhibits synthetic sick interactions at high temperature with mutants in
sphingolipid biosynthesis, including orm2Δ, yor1Δ, rsb1Δ, and isc1Δ.
Sphingoid long-chain bases (LCBs) dihydrosphingosine (DHS) and
phytosphingosine (PHS) and long-chain base phosphates (LCBPs) dihydrosphingosine1-phosphate (DHS-1P) and phytosphingosine-1-phosphate (PHS-1P) are important
signaling molecules. Accumulation of LCBPs inhibits the growth of yeast cells (Kim et al.
2000; X. Zhang et al. 2001). As illustrated in Fig. 6-6A, Orm2 negatively regulates the de
novo synthesis of LCBs by inhibiting the activity of serine palmitoyltransferase (SPT)
(Breslow et al. 2010; Han et al. 2010). Deletion of the ORM2 gene leads to the
accumulation of PHS (Han et al. 2010). Rsb1 and Yor1 are plasma membrane
transporters that transport LCBs and LCBPs, respectively (Boujaoude et al. 2001; Kihara
and Igarashi 2002). Loss of Rsb1 increases PHS sensitivity while induction of Rsb1
rescues PHS sensitivity associated with loss of Dpl1 and Lcb3 (Johnson et al. 2010;
Kihara and Igarashi 2002). Isc1 is a phosphosphingolipid phospholipase that degrades
complex sphingolipids to ceramides (Sawai et al. 2000). Although it is not clear if the loss
of Isc1 affects the levels of LCBs, the synthetic lethality between cld1Δ and orm2Δ, yor1Δ,
or rsb1Δ suggests that loss of Cld1 may result in the accumulation of LCBs, causing
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Figure 6-7. cld1Δ exhibit synthetic sickness with orm2Δ, yor1Δ, rsb1Δ, and isc1Δ.
(A) Sphingolipid metabolism in yeast cells. SPT, serine palmitoyltransferase; M(IP)2C,
mannosyldiinositolphosphorylceramide. (B) The indicated cells were grown to stationary
phase in SC medium. 5 μL from 10-fold serial dilutions of each culture (A550=0.5) were
spotted on SC plates and incubated at 30 ºC or 39 ºC for three days.
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decreased growth of these mutants.
In summary, it will be very interesting to investigate the functional importance of
Cld1 in sphingolipid metabolism. Future experiments can start with determining if (1)
cld1Δ exhibits PHS sensitivity, (2) levels of LCBs or LCBPs are elevated in cld1Δ, and (3)
overexpression of RSB1 rescues the decreased growth of cld1Δorm2Δ and cld1Δyor1Δ
at a high temperature.
1. Does ceramide link CL deficiency to decreased cell wall integrity (CWI) in crd1Δ?
The cell wall integrity (CWI) pathway in yeast is responsible for transcriptional
regulation of cell wall-related genes in response to cell wall stress, such as high
temperature and osmotic stress (Levin 2005). Protein kinase c 1 (Pkc1) is the only
member of the PKC family present in yeast cells and is essential for maintaining CWI in
response to heat stress (Levin 2005; Okamoto et al. 2002). PKC pathways in human cells
have been reported as targets for the treatment of diseases such as diabetes, bipolar
disorder, and Alzheimer’s disease (Lucke-Wold et al. 2015; Seed Ahmed et al. 2015;
Zarate and Manji 2009).
Zhong et al. showed that pgs1Δ, a mutant completely lacking both
phosphatidylglycerol (PG) (the precursor of CL) and CL, exhibits decreased PKCmediated phosphorylation of Slt2, the downstream MAPK of the PKC pathway (Zhong et
al. 2007). Consistent with the findings of Shen et al. (Shen et al. 2017), my preliminary
data also showed a decrease in phosphorylated Slt2 in response to elevated temperature
in crd1Δ (Fig. 6-8), which can produce PG but not CL, indicating that CL is required for
the heat stress response. However, the mechanism linking CL to the PKC-Slt2 pathway
is unknown.
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Isc1 catalyzes the synthesis of very-long-chain ceramide species from complex
sphingolipids during heat stress (Cowart et al. 2006). Ceramides have been shown to
directly interact with, activate, or inhibit PKCs in mammalian cells (Bessa et al. 2013; Fox
et al. 2007; Huwiler et al. 1996; Wang et al. 2005). Huang et al. showed that ceramides
with side chains of different lengths activate PKCs to different levels (H.-W. Huang et al.
1999). Yeast pgs1Δ exhibits defective cell growth and production of phytoceramides, as
does isc1Δ (Vaena de Avalos et al. 2005). CL binds to Isc1 in vitro and may be
responsible for its localization to the outer mitochondrial membrane (OMM) during the
late logarithmic and postdiauxic phases (Kitagaki et al. 2007; Okamoto et al. 2002; Vaena
de Avalos et al. 2004). Fig. 6-9 shows that isc1Δ is sensitive to cell wall perturbing
reagents caffeine and calcofluor-white (CFW), especially at high temperature.
Based on these findings, it is very tempting to hypothesize that Isc1 requires CLbinding to localize to the OMM during the late logarithmic and postdiauxic phases, and
the binding is required for producing very-long-chain ceramide species that activate the
CWI pathway.
While we are near the end of this dissertation, the metabolic defects and important
molecular pathways that are associated with CL and its remodeling have only revealed
the tip of an iceberg. It has been a very interesting journey for me. I invite my current and
future colleagues to expand on the picture I presented here. You may find the beauty of
science as I did along the way.
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Figure 6-8. Phosphorylation of Slt2p is decreased in crd1Δ.
WT and crd1Δ were grown to mid-logarithmic phase and shifted to 38°C for 2 hrs. Cell
lysates were analyzed by Western blot using P44/42 MAPK (Erk1/2) and phosphop44/42 MAPK (Erk1/2) (Thr202/Tyr204) rabbit antibodies.
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Figure 6-9. isc1Δ is sensitive to cell wall perturbing reagents caffeine and
calcofluor-white (CFW).
WT and crd1Δ were grown to stationary phase in YPD. 5 μL from 10-fold serial dilutions
of each culture (A550=0.5) were spotted on YPD with reagents as indicated. Plates were
incubated at 30 ºC or 39 ºC for three days.
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ABSTRACT
NOVEL INSIGHTS INTO THE CRITICAL ROLE OF CARDIOLIPIN IN CELLULAR
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Cardiolipin (CL) is the signature phospholipid of mitochondria. CL and its
remodeling exert critical roles in biological processes both inside and outside of
mitochondria. CL abnormalities have been associated with various mitochondrial
disorders and aging. Understanding the role of CL in mitochondrial physiology and cellular
metabolism could provide valuable insights into cell biology and human health.
Several metabolic alterations have been reported in CL-deficient cells, including
accumulated lactate, decreased PDH activity, and decreased TCA cycle function. This
dissertation connected these findings by showing abnormal NAD+ metabolism in various
models lacking CL. Importantly, it shows that NAD+ supplementation improves
mitochondrial function by increasing the NAD+/NADH ratio, which holds high potential in
normalizing the metabolic abnormalities of CL-deficient models. A model generated from
these findings, for the first time, explains the CL-associated metabolic alterations
systematically.
Mitochondrial physiology is highly associated with bioenergetics and metabolism.
This thesis, for the first time, describes a comprehensive analysis of yeast mitochondrial
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physiology in response to mitochondrial challenges induced chemically, genetically, and
physiologically, in the presence and absence of oxidizable CL. These findings provide
important insights into mitochondrial biology and add value to the yeast Saccharomyces
cerevisiae as an excellent model for studying mitochondrial disorders.
The importance of CL remodeling is highlighted by Barth syndrome (BTHS), which
is caused by disruptions of the tafazzin gene. Studies using yeast have revealed that
deletion of the CL-specific phospholipase Cld1 rescues defects of the yeast tafazzin
mutant taz1Δ. However, little is known about the functionality of Cld1. This thesis reported
a large-scale genetic screen, in which various novel cellular processes were identified to
be functionally important to cld1Δ. The findings pointed out several new directions for
understanding the role of CL remodeling in BTHS.
In summary, this thesis provides novel and fundamental understandings on the
critical roles of CL and its remodeling in cellular metabolism, mitochondrial physiology,
and other important biological processes.
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